TAR	B-DNA
independent	O
activation	O
of	O
the	O
human	O
immunodeficiency	O
virus	O
in	O
phorbol	O
ester	O
stimulated	O
T	B-cell_type
lymphocytes	I-cell_type
.	O

Multiple	B-DNA
regulatory	I-DNA
elements	I-DNA
in	O
the	O
human	B-DNA
immunodeficiency	I-DNA
virus	I-DNA
long	I-DNA
terminal	I-DNA
repeat	I-DNA
(	O
HIV	B-DNA
LTR	I-DNA
)	O
are	O
required	O
for	O
activation	O
of	O
HIV	O
gene	O
expression	O
.	O

Previous	O
transfection	O
studies	O
of	O
HIV	B-DNA
LTR	I-DNA
constructs	I-DNA
linked	O
to	O
the	O
chloramphenicol	B-DNA
acetyltransferase	I-DNA
gene	I-DNA
indicated	O
that	O
multiple	O
regulatory	B-DNA
regions	I-DNA
including	O
the	O
enhancer	B-DNA
,	O
SP1	B-DNA
,	O
TATA	B-DNA
and	O
TAR	B-DNA
regions	I-DNA
were	O
important	O
for	O
HIV	O
gene	O
expression	O
.	O

To	O
characterize	O
these	O
regulatory	B-DNA
elements	I-DNA
further	O
,	O
mutations	O
in	O
these	O
regions	O
were	O
inserted	O
into	O
both	O
the	O
5	O
'	O
and	O
3	O
'	O
HIV	B-DNA
LTRs	I-DNA
and	O
infectious	O
proviral	O
constructs	O
were	O
assembled	O
.	O

These	O
constructs	O
were	O
transfected	O
into	O
either	O
HeLa	B-cell_line
cells	I-cell_line
,	O
Jurkat	B-cell_line
cells	I-cell_line
or	O
U937	B-cell_line
cells	I-cell_line
in	O
both	O
the	O
presence	O
and	O
absence	O
of	O
phorbol	O
esters	O
which	O
have	O
previously	O
been	O
demonstrated	O
to	O
activate	O
HIV	O
gene	O
expression	O
.	O

Viral	O
gene	O
expression	O
was	O
assayed	O
by	O
the	O
level	O
of	O
p24	B-protein
gag	I-protein
protein	I-protein
released	O
from	O
cultures	O
transfected	O
with	O
the	O
proviral	O
constructs	O
.	O

Results	O
in	O
all	O
cell	O
lines	O
indicated	O
that	O
mutations	O
of	O
the	O
SP1	B-DNA
,	O
TATA	B-DNA
and	O
the	O
TAR	O
loop	O
and	O
stem	O
secondary	O
structure	O
resulted	O
in	O
marked	O
decreases	O
in	O
gene	O
expression	O
while	O
mutations	O
of	O
the	O
enhancer	B-DNA
motif	I-DNA
or	O
TAR	B-DNA
primary	I-DNA
sequence	I-DNA
resulted	O
in	O
only	O
slight	O
decreases	O
.	O

However	O
,	O
viruses	O
containing	O
mutations	O
in	O
either	O
the	O
TAR	B-DNA
loop	I-DNA
sequences	I-DNA
or	O
stem	O
secondary	O
structure	O
which	O
were	O
very	O
defective	O
for	O
gene	O
expression	O
in	O
untreated	O
Jurkat	B-cell_line
cells	I-cell_line
,	O
gave	O
nearly	O
wild-type	O
levels	O
of	O
gene	O
expression	O
in	O
phorbol	B-cell_line
ester-treated	I-cell_line
Jurkat	I-cell_line
cells	I-cell_line
but	O
not	O
in	O
phorbol	B-cell_line
ester-treated	I-cell_line
HeLa	I-cell_line
or	O
U937	B-cell_line
cells	I-cell_line
.	O

High	O
level	O
gene	O
expression	O
of	O
these	O
TAR	B-DNA
mutant	I-DNA
constructs	I-DNA
in	O
phorbol	B-cell_line
ester-treated	I-cell_line
Jurkat	I-cell_line
cells	I-cell_line
was	O
eliminated	O
by	O
second	O
site	O
mutations	O
in	O
the	O
enhancer	B-DNA
region	I-DNA
or	O
by	O
disruption	O
of	O
the	O
tat	B-DNA
gene	I-DNA
.	O

(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

The	NULL
EMBO	NULL
Journal	NULL
vol.9	NULL
no.13	NULL
pp.4417-4423	NULL
,	NULL
1990	NULL
TAR	NULL
independent	NULL
activation	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
phorbol	NULL
ester	NULL
stimulated	NULL
T	NULL
lymphocytes	NULL
David	NULL
Harrich	NULL
,	NULL
Joseph	NULL
Garcia	NULL
,	NULL
Ronald	NULL
Mitsuyasu	NULL
and	NULL
Richard	NULL
Gaynor	NULL
Departments	NULL
of	NULL
Pathology	NULL
,	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
and	NULL
Medicine	NULL
,	NULL
UCLA	NULL
School	NULL
of	NULL
Medicine	NULL
and	NULL
Wadsworth	NULL
Veteran	NULL
's	NULL
Hospital	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
CA	NULL
90024	NULL
,	NULL
USA	NULL
Communicated	NULL
by	NULL
P.Boulanger	NULL
Multiple	NULL
regulatory	NULL
elements	NULL
in	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
HIV	NULL
LTR	NULL
)	NULL
are	NULL
required	NULL
for	NULL
activation	NULL
of	NULL
HIV	NULL
gene	NULL
expression	NULL
.	NULL

Previous	NULL
transfection	NULL
studies	NULL
of	NULL
HIV	NULL
LTR	NULL
constructs	NULL
linked	NULL
to	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
gene	NULL
indicated	NULL
that	NULL
multiple	NULL
regulatory	NULL
regions	NULL
including	NULL
the	NULL
enhancer	NULL
,	NULL
SP1	NULL
,	NULL
TATA	NULL
and	NULL
TAR	NULL
regions	NULL
were	NULL
important	NULL
for	NULL
HIV	NULL
gene	NULL
expression	NULL
.	NULL

To	NULL
characterize	NULL
these	NULL
regulatory	NULL
elements	NULL
further	NULL
,	NULL
mutations	NULL
in	NULL
these	NULL
regions	NULL
were	NULL
inserted	NULL
into	NULL
both	NULL
the	NULL
5	NULL
and	NULL
3	NULL
'	NULL
HIV	NULL
LTRs	NULL
and	NULL
infectious	NULL
proviral	NULL
constructs	NULL
were	NULL
assembled	NULL
.	NULL

These	NULL
constructs	NULL
were	NULL
transfected	NULL
into	NULL
either	NULL
HeLa	NULL
cells	NULL
,	NULL
Jurkat	NULL
cells	NULL
or	NULL
U937	NULL
cells	NULL
in	NULL
both	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
phorbol	NULL
esters	NULL
which	NULL
have	NULL
previously	NULL
been	NULL
demonstrated	NULL
to	NULL
activate	NULL
HIV	NULL
gene	NULL
expression	NULL
.	NULL

Viral	NULL
gene	NULL
expression	NULL
was	NULL
assayed	NULL
by	NULL
the	NULL
level	NULL
of	NULL
p24	NULL
gag	NULL
protein	NULL
released	NULL
from	NULL
cultures	NULL
transfected	NULL
with	NULL
the	NULL
proviral	NULL
constructs	NULL
.	NULL

Results	NULL
in	NULL
all	NULL
cell	NULL
lines	NULL
indicated	NULL
that	NULL
mutations	NULL
of	NULL
the	NULL
SP1	NULL
,	NULL
TATA	NULL
and	NULL
the	NULL
TAR	NULL
loop	NULL
and	NULL
stem	NULL
secondary	NULL
structure	NULL
resulted	NULL
in	NULL
marked	NULL
decreases	NULL
in	NULL
gene	NULL
expression	NULL
while	NULL
mutations	NULL
of	NULL
the	NULL
enhancer	NULL
motif	NULL
or	NULL
TAR	NULL
primary	NULL
sequence	NULL
resulted	NULL
in	NULL
only	NULL
slight	NULL
decreases	NULL
.	NULL

However	NULL
,	NULL
viruses	NULL
containing	NULL
mutations	NULL
in	NULL
either	NULL
the	NULL
TAR	NULL
loop	NULL
sequences	NULL
or	NULL
stem	NULL
secondary	NULL
structure	NULL
which	NULL
were	NULL
very	NULL
defective	NULL
for	NULL
gene	NULL
expression	NULL
in	NULL
untreated	NULL
Jurkat	NULL
cells	NULL
,	NULL
gave	NULL
nearly	NULL
wild-type	NULL
levels	NULL
of	NULL
gene	NULL
expression	NULL
in	NULL
phorbol	NULL
ester-treated	NULL
Jurkat	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
phorbol	NULL
ester-treated	NULL
HeLa	NULL
or	NULL
U937	NULL
cells	NULL
.	NULL

High	NULL
level	NULL
gene	NULL
expression	NULL
of	NULL
these	NULL
TAR	NULL
mutant	NULL
constructs	NULL
in	NULL
phorbol	NULL
ester-treated	NULL
Jurkat	NULL
cells	NULL
was	NULL
eliminated	NULL
by	NULL
second	NULL
site	NULL
mutations	NULL
in	NULL
the	NULL
enhancer	NULL
region	NULL
or	NULL
by	NULL
disruption	NULL
of	NULL
the	NULL
fat	NULL
gene	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
in	NULL
stimulated	NULL
T	NULL
lymphocytes	NULL
fat	NULL
is	NULL
likely	NULL
capable	NULL
of	NULL
interacting	NULL
with	NULL
cellular	NULL
factors	NULL
which	NULL
bind	NULL
to	NULL
both	NULL
upstream	NULL
and	NULL
downstream	NULL
regulatory	NULL
elements	NULL
resulting	NULL
in	NULL
activation	NULL
of	NULL
HIV	NULL
gene	NULL
expression	NULL
.	NULL

Key	NULL
words	NULL
:	NULL
enhancer/human	NULL
-	NULL
immunodeficiency	NULL
virus/phorbol	NULL
esters/tat/transcriptional	NULL
regulation	NULL
Introduction	NULL
The	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
(	NULL
Barre-Sinousi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1983	NULL
;	NULL
Gallo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1984	NULL
;	NULL
Levy	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1984	NULL
;	NULL
Arya	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
)	NULL
is	NULL
dependent	NULL
on	NULL
specific	NULL
regulatory	NULL
regions	NULL
in	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
(	NULL
Rosen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
;	NULL
Jones	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Peterlin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Garcia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Muesing	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Sieckevitz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Feng	NULL
and	NULL
Holland	NULL
,	NULL
1988	NULL
;	NULL
Harrich	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

These	NULL
elements	NULL
Â©	NULL
Oxford	NULL
University	NULL
Press	NULL
can	NULL
be	NULL
divided	NULL
into	NULL
core	NULL
promoter	NULL
elements	NULL
required	NULL
for	NULL
activation	NULL
of	NULL
HIV	NULL
gene	NULL
expression	NULL
in	NULL
most	NULL
cell	NULL
lines	NULL
(	NULL
SP1	NULL
,	NULL
TATA	NULL
and	NULL
TAR	NULL
)	NULL
(	NULL
Rosen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
;	NULL
Peterlin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Garcia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Muesing	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Feng	NULL
and	NULL
Holland	NULL
,	NULL
1988	NULL
;	NULL
Hauber	NULL
and	NULL
Cullen	NULL
,	NULL
1988	NULL
;	NULL
Jakobovits	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Jones	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Garcia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Selby	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
and	NULL
elements	NULL
which	NULL
are	NULL
important	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
enhancer	NULL
and	NULL
IL-2	NULL
like	NULL
elements	NULL
)	NULL
(	NULL
Kaufman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Nabel	NULL
and	NULL
Baltimore	NULL
,	NULL
1987	NULL
;	NULL
Siekevitz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Tong-Starksen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Shaw	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Crabtree	NULL
,	NULL
1989	NULL
)	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
and	NULL
gel	NULL
retardation	NULL
have	NULL
indicated	NULL
that	NULL
these	NULL
regulatory	NULL
regions	NULL
serve	NULL
as	NULL
binding	NULL
sites	NULL
for	NULL
cellular	NULL
proteins	NULL
.	NULL

At	NULL
least	NULL
two	NULL
of	NULL
these	NULL
factors	NULL
,	NULL
NF-xB	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
the	NULL
enhancer	NULL
(	NULL
Nabel	NULL
and	NULL
Baltimore	NULL
,	NULL
1987	NULL
;	NULL
Kawakami	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
and	NULL
NF-AT	NULL
(	NULL
Durand	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Shaw	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Crabtree	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
the	NULL
IL-2	NULL
like	NULL
sequences	NULL
,	NULL
are	NULL
expressed	NULL
in	NULL
activated	NULL
but	NULL
not	NULL
resting	NULL
T	NULL
cells	NULL
.	NULL

SP1	NULL
(	NULL
Jones	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Harrich	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
,	NULL
TF-IID	NULL
(	NULL
Naka-jima	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Garcia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
and	NULL
the	NULL
TAR	NULL
DNA	NULL
(	NULL
Jones	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Wu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988b	NULL
;	NULL
Garcia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
and	NULL
RNA	NULL
(	NULL
Gatignol	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Gaynor	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
binding	NULL
proteins	NULL
are	NULL
expressed	NULL
constitutively	NULL
in	NULL
most	NULL
cells	NULL
.	NULL

SP1	NULL
(	NULL
Jones	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Harrich	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
,	NULL
TATA	NULL
(	NULL
Garcia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
,	NULL
1989	NULL
;	NULL
Jones	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
and	NULL
TAR	NULL
(	NULL
Rosen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
;	NULL
Garcia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
,	NULL
1989	NULL
;	NULL
Feng	NULL
and	NULL
Holland	NULL
,	NULL
1988	NULL
;	NULL
Hauber	NULL
and	NULL
Cullen	NULL
,	NULL
1988	NULL
;	NULL
Jakobovits	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Berkhout	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Braddock	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Laspia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Selby	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
regions	NULL
comprise	NULL
elements	NULL
required	NULL
for	NULL
high	NULL
levels	NULL
of	NULL
HIV	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
SPI	NULL
and	NULL
TATA	NULL
elements	NULL
are	NULL
important	NULL
in	NULL
both	NULL
basal	NULL
and	NULL
tar-induced	NULL
gene	NULL
expression	NULL
(	NULL
Rosen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
;	NULL
Garcia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
,	NULL
1989	NULL
;	NULL
Jones	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Harrich	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

The	NULL
TAR	NULL
region	NULL
has	NULL
been	NULL
demonstrated	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
tat	NULL
activation	NULL
(	NULL
Rosen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
;	NULL
Garcia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
,	NULL
1989	NULL
;	NULL
Feng	NULL
and	NULL
Holland	NULL
,	NULL
1988	NULL
;	NULL
Hauber	NULL
and	NULL
Cullen	NULL
,	NULL
1988	NULL
;	NULL
Jakobovitz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Berkhout	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Braddock	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Laspia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Selby	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

This	NULL
region	NULL
has	NULL
been	NULL
mapped	NULL
by	NULL
mutagenesis	NULL
between	NULL
-17	NULL
and	NULL
+44	NULL
in	NULL
the	NULL
HIV	NULL
LTR	NULL
and	NULL
it	NULL
is	NULL
capable	NULL
of	NULL
forming	NULL
a	NULL
stable	NULL
RNA	NULL
stem-loop	NULL
structure	NULL
(	NULL
Muesing	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Feng	NULL
and	NULL
Holland	NULL
,	NULL
1988	NULL
;	NULL
Hauber	NULL
and	NULL
Cullen	NULL
,	NULL
1988	NULL
;	NULL
Jakobovits	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Garcia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Hauber	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Selby	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

Both	NULL
stem	NULL
base	NULL
pairing	NULL
and	NULL
the	NULL
primary	NULL
sequence	NULL
of	NULL
the	NULL
loop	NULL
are	NULL
required	NULL
for	NULL
high	NULL
levels	NULL
of	NULL
fat	NULL
activation	NULL
(	NULL
Feng	NULL
and	NULL
Holland	NULL
,	NULL
1988	NULL
;	NULL
Garcia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Selby	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

The	NULL
TAR	NULL
region	NULL
serves	NULL
as	NULL
the	NULL
binding	NULL
site	NULL
at	NULL
the	NULL
RNA	NULL
level	NULL
for	NULL
both	NULL
tat	NULL
(	NULL
Dingwall	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
and	NULL
a	NULL
group	NULL
of	NULL
cellular	NULL
proteins	NULL
known	NULL
as	NULL
URBP	NULL
(	NULL
Gaynor	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Gatignol	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
,	NULL
and	NULL
at	NULL
the	NULL
DNA	NULL
level	NULL
for	NULL
cellular	NULL
proteins	NULL
UBPI1	NULL
and	NULL
UBP2	NULL
(	NULL
Jones	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Wu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988b	NULL
;	NULL
Garcia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

Several	NULL
studies	NULL
have	NULL
examined	NULL
the	NULL
role	NULL
of	NULL
mutated	NULL
viral	NULL
regulatory	NULL
regions	NULL
in	NULL
the	NULL
HIV	NULL
LTR	NULL
in	NULL
the	NULL
context	NULL
of	NULL
infectious	NULL
virus	NULL
(	NULL
Lu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Leonard	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

One	NULL
study	NULL
using	NULL
constructs	NULL
containing	NULL
deletions	NULL
in	NULL
the	NULL
HIV	NULL
LTR	NULL
4417	NULL
Ll	NULL
clades	NULL
ems	NULL
ules	NULL
co	NULL
dis	NULL
cms	NULL
comin	NULL
cain	NULL
came	NULL
oue	NULL
ante..	NULL
an	NULL
cami	NULL
.	NULL

aie	NULL
afte	NULL
cabo	NULL
c	NULL
lbe	NULL
snes	NULL
amc	NULL
mes	NULL
vas	NULL
cans	NULL
mis	NULL
can	NULL
D.Harrich	NULL
et	NULL
al	NULL
.	NULL

demonstrated	NULL
an	NULL
effect	NULL
on	NULL
removal	NULL
of	NULL
potential	NULL
negative	NULL
regulatory	NULL
elements	NULL
on	NULL
viral	NULL
growth	NULL
(	NULL
Lu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

Another	NULL
study	NULL
showed	NULL
that	NULL
mutations	NULL
of	NULL
the	NULL
enhancer	NULL
motif	NULL
did	NULL
not	NULL
result	NULL
in	NULL
marked	NULL
defects	NULL
in	NULL
viral	NULL
growth	NULL
unless	NULL
coupled	NULL
to	NULL
additional	NULL
mutations	NULL
of	NULL
the	NULL
SP1	NULL
binding	NULL
site	NULL
(	NULL
Leonard	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

The	NULL
focus	NULL
of	NULL
both	NULL
of	NULL
these	NULL
studies	NULL
was	NULL
to	NULL
determine	NULL
the	NULL
effect	NULL
of	NULL
these	NULL
HIV	NULL
LTR	NULL
regulatory	NULL
region	NULL
mutations	NULL
on	NULL
viral	NULL
growth	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
role	NULL
of	NULL
viral	NULL
regulatory	NULL
regions	NULL
in	NULL
the	NULL
context	NULL
of	NULL
proviral	NULL
constructs	NULL
,	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
LTRs	NULL
containing	NULL
mutations	NULL
of	NULL
either	NULL
the	NULL
enhancer	NULL
,	NULL
SP1	NULL
,	NULL
TATA	NULL
or	NULL
TAR	NULL
regions	NULL
or	NULL
multiple	NULL
regulatory	NULL
domains	NULL
were	NULL
inserted	NULL
into	NULL
infectious	NULL
virus	NULL
constructs	NULL
.	NULL

These	NULL
constructs	NULL
were	NULL
transfected	NULL
into	NULL
either	NULL
HeLa	NULL
,	NULL
U937	NULL
or	NULL
Jurkat	NULL
cells	NULL
in	NULL
both	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
phorbol	NULL
esters	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
indicated	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
phorbol	NULL
esters	NULL
can	NULL
stimulate	NULL
HIV	NULL
gene	NULL
expression	NULL
(	NULL
Harada	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
)	NULL
.	NULL

The	NULL
quantity	NULL
of	NULL
p24	NULL
gag	NULL
protein	NULL
released	NULL
from	NULL
cultures	NULL
transfected	NULL
with	NULL
these	NULL
proviral	NULL
constructs	NULL
was	NULL
determined	NULL
from	NULL
48	NULL
to	NULL
96	NULL
h	NULL
post-transfection	NULL
to	NULL
determine	NULL
the	NULL
roles	NULL
of	NULL
these	NULL
mutations	NULL
on	NULL
HIV	NULL
gene	NULL
expression	NULL
.	NULL

Alterations	NULL
in	NULL
transfection	NULL
efficiency	NULL
were	NULL
monitored	NULL
by	NULL
the	NULL
inclusion	NULL
of	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
LTR	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
RSV	NULL
CAT	NULL
)	NULL
constructs	NULL
into	NULL
each	NULL
set	NULL
of	NULL
transfections	NULL
.	NULL

The	NULL
role	NULL
of	NULL
mutations	NULL
of	NULL
the	NULL
fat	NULL
gene	NULL
in	NULL
these	NULL
constructs	NULL
was	NULL
also	NULL
AR	NULL
5	NULL
;	NULL
C	NULL
â¬	NULL
x	NULL
determined	NULL
.	NULL

These	NULL
studies	NULL
define	NULL
the	NULL
patterns	NULL
of	NULL
early	NULL
gene	NULL
expression	NULL
in	NULL
proviral	NULL
constructs	NULL
containing	NULL
promoter	NULL
element	NULL
mutations	NULL
.	NULL

Results	NULL
Construction	NULL
of	NULL
HIV	NULL
LTR	NULL
mutated	NULL
constructs	NULL
Previously	NULL
we	NULL
constructed	NULL
oligonucleotide-directed	NULL
mutations	NULL
in	NULL
the	NULL
enhancer	NULL
,	NULL
SP1	NULL
,	NULL
TATA	NULL
and	NULL
TAR	NULL
regions	NULL
in	NULL
the	NULL
HIV	NULL
LTR	NULL
(	NULL
Garcia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Gaynor	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Harrich	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

These	NULL
mutant	NULL
constructs	NULL
were	NULL
previously	NULL
assayed	NULL
in	NULL
both	NULL
DNase	NULL
I	NULL
footprinting	NULL
assays	NULL
and	NULL
transient	NULL
expression	NULL
assays	NULL
using	NULL
truncated	NULL
LTR	NULL
constructs	NULL
linked	NULL
to	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
gene	NULL
.	NULL

The	NULL
mutation	NULL
of	NULL
the	NULL
enhancer	NULL
altered	NULL
cellular	NULL
protein	NULL
binding	NULL
to	NULL
both	NULL
NF-xB	NULL
motifs	NULL
in	NULL
this	NULL
region	NULL
(	NULL
NENH1	NULL
and	NULL
NENH2	NULL
)	NULL
,	NULL
the	NULL
mutation	NULL
of	NULL
their	NULL
SP1	NULL
region	NULL
eliminated	NULL
SP1	NULL
binding	NULL
to	NULL
all	NULL
three	NULL
SP1	NULL
sites	NULL
(	NULL
NSP1	NULL
,	NULL
NSP2	NULL
,	NULL
NSP3	NULL
)	NULL
,	NULL
and	NULL
the	NULL
TATA	NULL
mutant	NULL
(	NULL
NTATA	NULL
)	NULL
altered	NULL
binding	NULL
of	NULL
proteins	NULL
to	NULL
this	NULL
region	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

The	NULL
mutations	NULL
in	NULL
the	NULL
TAR	NULL
region	NULL
included	NULL
a	NULL
single	NULL
point	NULL
mutation	NULL
of	NULL
the	NULL
loop	NULL
(	NULL
+34	NULL
)	NULL
,	NULL
a	NULL
4	NULL
bp	NULL
substitution	NULL
in	NULL
the	NULL
loop	NULL
(	NULL
+31/	NULL
+34	NULL
)	NULL
,	NULL
interruption	NULL
of	NULL
much	NULL
of	NULL
the	NULL
primary	NULL
sequence	NULL
of	NULL
the	NULL
stem	NULL
with	NULL
preservation	NULL
of	NULL
stem	NULL
base	NULL
pairing	NULL
and	NULL
stem	NULL
energy	NULL
(	NULL
ATAR-sense	NULL
)	NULL
,	NULL
and	NULL
interruption	NULL
of	NULL
stem	NULL
base	NULL
pairing	NULL
(	NULL
+11/+14	NULL
,	NULL
+40/+43	NULL
)	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

U	NULL
G	NULL
Â¢-	NULL
8	NULL
G	NULL
-C	NULL
T	NULL
A	NULL
-	NULL
6	NULL
'	NULL
-	NULL
@	NULL
U	NULL
-2	NULL
H	NULL
-	NULL
Â®	NULL
a	NULL
-C	NULL
*	NULL
%	NULL
40/443	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Schematic	NULL
of	NULL
HIV	NULL
LTR	NULL
mutations	NULL
.	NULL

A	NULL
portion	NULL
of	NULL
the	NULL
HIV	NULL
LTR	NULL
extending	NULL
from	NULL
-127	NULL
to	NULL
+1	NULL
is	NULL
indicated	NULL
.	NULL

The	NULL
position	NULL
and	NULL
nucleotide	NULL
changes	NULL
for	NULL
mutations	NULL
of	NULL
both	NULL
NF-xB	NULL
motifs	NULL
in	NULL
the	NULL
enhancer	NULL
(	NULL
ENH	NULL
1	NULL
and	NULL
ENH	NULL
2	NULL
)	NULL
,	NULL
the	NULL
three	NULL
SPI	NULL
sites	NULL
(	NULL
NSPI	NULL
,	NULL
NSP2	NULL
and	NULL
NSP3	NULL
)	NULL
and	NULL
the	NULL
TATA	NULL
element	NULL
(	NULL
NTATA	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

The	NULL
TAR	NULL
mutations	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
RNA	NULL
secondary	NULL
structure	NULL
are	NULL
indicated	NULL
.	NULL

The	NULL
TAR	NULL
mutations	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
RNA	NULL
secondary	NULL
structure	NULL
are	NULL
indicated	NULL
.	NULL

The	NULL
dark	NULL
boxes	NULL
indicate	NULL
mutated	NULL
nucleotides	NULL
for	NULL
a	NULL
point	NULL
mutation	NULL
of	NULL
the	NULL
loop	NULL
(	NULL
+34	NULL
)	NULL
,	NULL
a	NULL
4	NULL
bp	NULL
loop	NULL
substitution	NULL
(	NULL
+31/+34	NULL
)	NULL
,	NULL
a	NULL
change	NULL
in	NULL
the	NULL
primary	NULL
sequence	NULL
of	NULL
TAR	NULL
(	NULL
ATAR-sense	NULL
)	NULL
,	NULL
and	NULL
a	NULL
stem	NULL
disruption	NULL
of	NULL
the	NULL
stem	NULL
structure	NULL
(	NULL
+11/+14	NULL
,	NULL
+40/	NULL
+43	NULL
)	NULL
.	NULL

4418	NULL
Each	NULL
of	NULL
these	NULL
mutations	NULL
was	NULL
placed	NULL
into	NULL
both	NULL
the	NULL
5	NULL
'	NULL
and	NULL
3	NULL
``	NULL
LTRs	NULL
and	NULL
inserted	NULL
into	NULL
a	NULL
plasmid	NULL
containing	NULL
a	NULL
derivative	NULL
of	NULL
ARV-2B	NULL
(	NULL
Levy	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1984	NULL
;	NULL
Luciw	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1984	NULL
)	NULL
.	NULL

This	NULL
proviral	NULL
construct	NULL
was	NULL
able	NULL
to	NULL
replicate	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
lymphoid	NULL
and	NULL
monocyte	NULL
cell	NULL
lines	NULL
(	NULL
U937	NULL
,	NULL
H9	NULL
)	NULL
as	NULL
determined	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
both	NULL
high	NULL
levels	NULL
of	NULL
secreted	NULL
p24	NULL
gag	NULL
protein	NULL
and	NULL
reverse	NULL
transcriptase	NULL
in	NULL
tissue	NULL
culture	NULL
media	NULL
samples	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

p24	NULL
antigen	NULL
(	NULL
Ag	NULL
)	NULL
assays	NULL
in	NULL
this	NULL
study	NULL
were	NULL
performed	NULL
at	NULL
48	NULL
h	NULL
post-transfection	NULL
with	NULL
Jurkat	NULL
and	NULL
U937	NULL
cells	NULL
in	NULL
both	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
phorbol	NULL
esters	NULL
.	NULL

This	NULL
is	NULL
prior	NULL
to	NULL
the	NULL
onset	NULL
of	NULL
viral	NULL
replication	NULL
.	NULL

p24	NULL
Ag	NULL
assays	NULL
on	NULL
HeLa	NULL
cells	NULL
were	NULL
performed	NULL
at	NULL
96	NULL
h	NULL
post-transfection	NULL
due	NULL
to	NULL
the	NULL
inability	NULL
to	NULL
detect	NULL
substantial	NULL
levels	NULL
of	NULL
this	NULL
protein	NULL
at	NULL
earlier	NULL
times	NULL
.	NULL

A	NULL
diagram	NULL
of	NULL
the	NULL
mutations	NULL
introduced	NULL
into	NULL
the	NULL
LTRs	NULL
in	NULL
these	NULL
constructs	NULL
is	NULL
shown	NULL
in	NULL
Figure	NULL
1	NULL
.	NULL

TAR	NULL
independent	NULL
activation	NULL
of	NULL
HIV	NULL
in	NULL
PMA-treated	NULL
Jurkat	NULL
cells	NULL
Each	NULL
of	NULL
the	NULL
proviral	NULL
constructs	NULL
was	NULL
introduced	NULL
into	NULL
Jurkat	NULL
cells	NULL
by	NULL
electroporation	NULL
.	NULL

An	NULL
RSV	NULL
CAT	NULL
plasmid	NULL
was	NULL
included	NULL
in	NULL
each	NULL
transfection	NULL
to	NULL
normalize	NULL
for	NULL
differences	NULL
in	NULL
transfection	NULL
efficiency	NULL
.	NULL

At	NULL
24	NULL
h	NULL
post-transfection	NULL
,	NULL
the	NULL
transfections	NULL
were	NULL
divided	NULL
and	NULL
one	NULL
set	NULL
was	NULL
untreated	NULL
and	NULL
the	NULL
other	NULL
treated	NULL
with	NULL
either	NULL
phorbol	NULL
ester	NULL
(	NULL
PMA	NULL
)	NULL
or	NULL
PMA	NULL
and	NULL
phytohemag-glutinin	NULL
(	NULL
PHA	NULL
)	NULL
.	NULL

Supernatants	NULL
were	NULL
harvested	NULL
at	NULL
48	NULL
h	NULL
post-transfection	NULL
and	NULL
p24	NULL
Ag	NULL
levels	NULL
were	NULL
quantitated	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
.	NULL

In	NULL
untreated	NULL
Jurkat	NULL
cells	NULL
,	NULL
the	NULL
wild-type	NULL
construct	NULL
yielded	NULL
~8000	NULL
pg/ml	NULL
of	NULL
p24	NULL
Ag	NULL
antigen	NULL
(	NULL
Ag	NULL
)	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
.	NULL

Mutations	NULL
of	NULL
both	NULL
xB	NULL
motifs	NULL
in	NULL
the	NULL
enhancer	NULL
resulted	NULL
in	NULL
a	NULL
<	NULL
2-fold	NULL
decrease	NULL
in	NULL
p24	NULL
Ag	NULL
levels	NULL
.	NULL

Mutations	NULL
of	NULL
either	NULL
the	NULL
three	NULL
SP1	NULL
binding	NULL
sites	NULL
or	NULL
the	NULL
TATA	NULL
element	NULL
resulted	NULL
in	NULL
levels	NULL
of	NULL
p24	NULL
only	NULL
slightly	NULL
above	NULL
detection	NULL
limits	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
.	NULL

Mutations	NULL
of	NULL
both	NULL
the	NULL
TAR	NULL
loop	NULL
and	NULL
stem	NULL
structure	NULL
were	NULL
also	NULL
tested	NULL
.	NULL

A	NULL
single	NULL
base	NULL
pair	NULL
mutation	NULL
of	NULL
the	NULL
loop	NULL
sequences	NULL
(	NULL
+34	NULL
)	NULL
resulted	NULL
in	NULL
an	NULL
~10-fold	NULL
decrease	NULL
in	NULL
p24	NULL
Ag	NULL
levels	NULL
compared	NULL
with	NULL
the	NULL
wild-type	NULL
construct	NULL
.	NULL

A	NULL
4	NULL
bp	NULL
substitution	NULL
in	NULL
the	NULL
loop	NULL
sequences	NULL
(	NULL
+31/	NULL
+34	NULL
)	NULL
resulted	NULL
in	NULL
a	NULL
35-fold	NULL
decrease	NULL
in	NULL
p24	NULL
Ag	NULL
levels	NULL
compared	NULL
with	NULL
the	NULL
wild-type	NULL
construct	NULL
.	NULL

Mutations	NULL
in	NULL
the	NULL
primary	NULL
sequence	NULL
of	NULL
the	NULL
TAR	NULL
region	NULL
(	NULL
ATAR-sense	NULL
)	NULL
which	NULL
left	NULL
stem	NULL
base	NULL
pairing	NULL
and	NULL
stem	NULL
energy	NULL
intact	NULL
exhibited	NULL
a	NULL
2.5-fold	NULL
decrease	NULL
in	NULL
gene	NULL
expression	NULL
.	NULL

A	NULL
mutation	NULL
that	NULL
disrupted	NULL
stem	NULL
base	NULL
pairing	NULL
in	NULL
the	NULL
TAR	NULL
region	NULL
(	NULL
+11/+14/	NULL
+40	NULL
+43	NULL
)	NULL
resulted	NULL
in	NULL
a	NULL
40-fold	NULL
decrease	NULL
in	NULL
gene	NULL
expression	NULL
.	NULL

Thus	NULL
multiple	NULL
upstream	NULL
and	NULL
downstream	NULL
regulatory	NULL
regions	NULL
alter	NULL
early	NULL
viral	NULL
gene	NULL
expression	NULL
.	NULL

Each	NULL
of	NULL
these	NULL
constructs	NULL
was	NULL
also	NULL
assayed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMA	NULL
.	NULL

Minimal	NULL
differences	NULL
were	NULL
noted	NULL
in	NULL
the	NULL
level	NULL
of	NULL
induction	NULL
of	NULL
these	NULL
constructs	NULL
by	NULL
PMA	NULL
alone	NULL
or	NULL
PMA	NULL
in	NULL
combination	NULL
with	NULL
PHA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
the	NULL
following	NULL
experiments	NULL
,	NULL
transfections	NULL
containing	NULL
only	NULL
PMA	NULL
treatment	NULL
alone	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
wild-type	NULL
HIV	NULL
construct	NULL
was	NULL
only	NULL
slightly	NULL
induced	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMA	NULL
as	NULL
compared	NULL
with	NULL
its	NULL
absence	NULL
.	NULL

Similar	NULL
low	NULL
levels	NULL
of	NULL
PMA	NULL
induction	NULL
were	NULL
seen	NULL
with	NULL
the	NULL
enhancer	NULL
mutation	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
SP1	NULL
and	NULL
the	NULL
TATA	NULL
mutants	NULL
were	NULL
extremely	NULL
low	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMA	NULL
as	NULL
they	NULL
were	NULL
in	NULL
its	NULL
absence	NULL
.	NULL

However	NULL
,	NULL
the	NULL
results	NULL
with	NULL
several	NULL
of	NULL
the	NULL
TAR	NULL
region	NULL
mutants	NULL
were	NULL
unexpected	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
.	NULL

p24	NULL
Ag	NULL
levels	NULL
for	NULL
both	NULL
mutations	NULL
in	NULL
the	NULL
loop	NULL
region	NULL
,	NULL
either	NULL
a	NULL
single	NULL
base	NULL
pair	NULL
mutation	NULL
(	NULL
+34	NULL
)	NULL
or	NULL
a	NULL
4	NULL
bp	NULL
substitution	NULL
(	NULL
+31/+34	NULL
)	NULL
were	NULL
strongly	NULL
induced	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
PMA	NULL
.	NULL

This	NULL
induction	NULL
ranged	NULL
from	NULL
8-fold	NULL
(	NULL
+34	NULL
)	NULL
to	NULL
20-fold	NULL
(	NULL
+31/	NULL
+34	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
a	NULL
mutation	NULL
that	NULL
disrupted	NULL
the	NULL
stem	NULL
structure	NULL
(	NULL
+11/+14/+40/+43	NULL
)	NULL
resulted	NULL
in	NULL
a	NULL
HIV	NULL
activation	NULL
15-fold	NULL
level	NULL
of	NULL
induction	NULL
in	NULL
p24	NULL
Ag	NULL
levels	NULL
.	NULL

This	NULL
level	NULL
of	NULL
p24	NULL
Ag	NULL
induction	NULL
was	NULL
much	NULL
greater	NULL
than	NULL
that	NULL
seen	NULL
with	NULL
the	NULL
wild-type	NULL
or	NULL
enhancer	NULL
mutant	NULL
constructs	NULL
.	NULL

A	NULL
mutation	NULL
of	NULL
the	NULL
TAR	NULL
region	NULL
primary	NULL
sequence	NULL
(	NULL
ATAR-sense	NULL
)	NULL
was	NULL
only	NULL
induced	NULL
2	NULL
to	NULL
3-fold	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
in	NULL
activated	NULL
Jurkat	NULL
cells	NULL
,	NULL
two	NULL
critical	NULL
determinants	NULL
of	NULL
TAR	NULL
function	NULL
,	NULL
the	NULL
loop	NULL
sequences	NULL
and	NULL
the	NULL
stem	NULL
secondary	NULL
structure	NULL
,	NULL
were	NULL
much	NULL
less	NULL
critical	NULL
for	NULL
gene	NULL
expression	NULL
than	NULL
in	NULL
unstimulated	NULL
Jurkat	NULL
cells	NULL
.	NULL

This	NULL
was	NULL
demonstrated	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
PMA	NULL
,	NULL
loop	NULL
and	NULL
stem	NULL
mutants	NULL
were	NULL
10	NULL
to	NULL
35-fold	NULL
less	NULL
active	NULL
than	NULL
wild-type	NULL
while	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMA	NULL
these	NULL
same	NULL
mutants	NULL
are	NULL
only	NULL
2	NULL
to	NULL
3-fold	NULL
decreased	NULL
compared	NULL
with	NULL
wild-type	NULL
.	NULL

The	NULL
wild-type	NULL
construct	NULL
was	NULL
only	NULL
minimally	NULL
induced	NULL
by	NULL
PMA	NULL
as	NULL
was	NULL
the	NULL
enhancer	NULL
mutant	NULL
.	NULL

Thus	NULL
,	NULL
mechanisms	NULL
exist	NULL
in	NULL
PMA	NULL
-treated	NULL
Jurkay	NULL
cells	NULL
to	NULL
induce	NULL
strongly	NULL
the	NULL
gene	NULL
expression	NULL
of	NULL
proviral	NULL
constructs	NULL
containing	NULL
mutations	NULL
in	NULL
the	NULL
HIV	NULL
TAR	NULL
region	NULL
.	NULL

The	NULL
enhancer	NULL
region	NULL
is	NULL
required	NULL
for	NULL
TAR	NULL
independent	NULL
activation	NULL
of	NULL
HIV	NULL
gene	NULL
expression	NULL
in	NULL
PMA-treated	NULL
Jurkat	NULL
cells	NULL
Previous	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
enhancer	NULL
element	NULL
composed	NULL
of	NULL
two	NULL
NF-xB	NULL
motifs	NULL
was	NULL
critical	NULL
for	NULL
PMA	NULL
activation	NULL
of	NULL
the	NULL
HIV	NULL
LTR	NULL
(	NULL
Kaufman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Nabel	NULL
and	NULL
Baltimore	NULL
,	NULL
1987	NULL
;	NULL
Siekevitz	NULL
er	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Tong-Starksen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
.	NULL

These	NULL
studies	NULL
were	NULL
performed	NULL
using	NULL
transient	NULL
expression	NULL
assays	NULL
with	NULL
the	NULL
HIV	NULL
LTR	NULL
fused	NULL
to	NULL
the	NULL
CAT	NULL
gene	NULL
.	NULL

However	NULL
,	NULL
our	NULL
studies	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
and	NULL
previous	NULL
studies	NULL
using	NULL
infectious	NULL
proviral	NULL
constructs	NULL
did	NULL
not	NULL
indicate	NULL
that	NULL
the	NULL
enhancer	NULL
element	NULL
had	NULL
marked	NULL
effects	NULL
on	NULL
HIV	NULL
gene	NULL
expression	NULL
(	NULL
Leonard	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
enhancer	NULL
region	NULL
was	NULL
involved	NULL
in	NULL
PMA	NULL
activation	NULL
of	NULL
TAR	NULL
mutants	NULL
,	NULL
we	NULL
constructed	NULL
double	NULL
regulatory	NULL
region	NULL
mutants	NULL
in	NULL
which	NULL
a	NULL
mutated	NULL
enhancer	NULL
region	NULL
was	NULL
fused	NULL
to	NULL
TAR	NULL
mutations	NULL
in	NULL
either	NULL
the	NULL
loop	NULL
,	NULL
stem	NULL
or	NULL
primary	NULL
sequence	NULL
.	NULL

These	NULL
viral	NULL
constructs	NULL
containing	NULL
either	NULL
double	NULL
of	NULL
single	NULL
mutations	NULL
were	NULL
transfected	NULL
into	NULL
untreated	NULL
or	NULL
PMA-treated	NULL
Jurkat	NULL
cells	NULL
and	NULL
p24	NULL
Ag	NULL
levels	NULL
determined	NULL
.	NULL

10000	NULL
O	NULL
p24	NULL
pgimi	NULL
TJ	NULL
|	NULL
p24	NULL
pgiml	NULL
(	NULL
PMA	NULL
Songimi	NULL
)	NULL
8000	NULL
6000	NULL
p24	NULL
pg/ml	NULL
o	NULL
T_	NULL
o	NULL
g	NULL
&	NULL
TATA	NULL
a4	NULL
)	NULL
a4	NULL
)	NULL
(	NULL
control	NULL
7	NULL
+	NULL
wiLo	NULL
TYPE	NULL
(	NULL
+317	NULL
aTAR-sonse	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Expression	NULL
of	NULL
HIV	NULL
mutants	NULL
in	NULL
untreated	NULL
and	NULL
PMA-treated	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
p24	NULL
Ag	NULL
(	NULL
pg/ml	NULL
)	NULL
detected	NULL
in	NULL
the	NULL
tissue	NULL
culture	NULL
media	NULL
at	NULL
48	NULL
h	NULL
post-transfection	NULL
for	NULL
the	NULL
wild-type	NULL
construct	NULL
and	NULL
mutations	NULL
of	NULL
the	NULL
enhancer	NULL
,	NULL
SP1	NULL
,	NULL
TATA	NULL
,	NULL
point	NULL
mutations	NULL
of	NULL
the	NULL
loop	NULL
(	NULL
+34	NULL
)	NULL
,	NULL
4	NULL
bp	NULL
substitutions	NULL
of	NULL
the	NULL
loop	NULL
(	NULL
+31/+34	NULL
)	NULL
,	NULL
primary	NULL
sequences	NULL
of	NULL
the	NULL
stem	NULL
(	NULL
ATAR-sense	NULL
)	NULL
,	NULL
and	NULL
stem	NULL
secondary	NULL
structure	NULL
(	NULL
+11/+14	NULL
,	NULL
+40/+43	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

All	NULL
transfections	NULL
were	NULL
normalized	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
RSV	NULL
CAT	NULL
.	NULL

The	NULL
clear	NULL
boxes	NULL
indicate	NULL
expression	NULL
in	NULL
untreated	NULL
Jurkat	NULL
cells	NULL
and	NULL
the	NULL
hatched	NULL
boxes	NULL
indicate	NULL
expression	NULL
in	NULL
PMA-treated	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
are	NULL
the	NULL
average	NULL
of	NULL
four	NULL
independent	NULL
experiments	NULL
with	NULL
the	NULL
standard	NULL
deviation	NULL
indicated	NULL
.	NULL

4419	NULL
D.Harrich	NULL
et	NULL
al	NULL
.	NULL

10000	NULL
8000	NULL
C	NULL
p24	NULL
pg/m	NULL
!	NULL

Â©	NULL
pg/m	NULL
!	NULL

(	NULL
PMA	NULL
50	NULL
ng/m	NULL
)	NULL
E6000	NULL
~	NULL
&	NULL
a	NULL
Â§	NULL
Â§	NULL
4000	NULL
2000	NULL
0	NULL
w	NULL
&	NULL
-d	NULL
#	NULL
a	NULL
a	NULL
F	NULL
a	NULL
&	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Expression	NULL
of	NULL
HIV	NULL
enhancer-TAR	NULL
mutants	NULL
in	NULL
untreated	NULL
and	NULL
PMA-treated	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
p24	NULL
Ag	NULL
(	NULL
pg/m	NULL
!	NULL

l	NULL
)	NULL
detected	NULL
in	NULL
the	NULL
tissue	NULL
culture	NULL
media	NULL
at	NULL
48	NULL
h	NULL
post-transfection	NULL
for	NULL
the	NULL
wild-type	NULL
construct	NULL
and	NULL
mutations	NULL
of	NULL
the	NULL
enhancer	NULL
,	NULL
4	NULL
bp	NULL
substitutions	NULL
of	NULL
the	NULL
loop	NULL
(	NULL
+31/+34	NULL
)	NULL
,	NULL
primary	NULL
sequence	NULL
of	NULL
the	NULL
stem	NULL
(	NULL
ATAR-sense	NULL
)	NULL
,	NULL
and	NULL
stem	NULL
secondary	NULL
structure	NULL
(	NULL
+11/+14	NULL
,	NULL
+40/+43	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

The	NULL
enhancer	NULL
mutation	NULL
was	NULL
also	NULL
coupled	NULL
to	NULL
each	NULL
of	NULL
the	NULL
following	NULL
TAR	NULL
mutants	NULL
;	NULL
ENH/	NULL
(	NULL
+31/+34	NULL
)	NULL
,	NULL
ENH/ATAR-sense	NULL
,	NULL
and	NULL
ENH/	NULL
(	NULL
+11/+	NULL
14	NULL
,	NULL
+40/	NULL
+43	NULL
)	NULL
.	NULL

All	NULL
transfections	NULL
were	NULL
normalized	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
RSV	NULL
CAT	NULL
.	NULL

The	NULL
clear	NULL
boxes	NULL
indicate	NULL
expression	NULL
in	NULL
untreated	NULL
Jurkat	NULL
cells	NULL
and	NULL
the	NULL
hatched	NULL
boxes	NULL
indicate	NULL
expression	NULL
in	NULL
PMA-treated	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
are	NULL
the	NULL
average	NULL
of	NULL
four	NULL
independent	NULL
experiments	NULL
with	NULL
the	NULL
standard	NULL
deviation	NULL
indicated	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
3	NULL
,	NULL
mutations	NULL
of	NULL
the	NULL
enhancer	NULL
alone	NULL
had	NULL
minimal	NULL
effects	NULL
on	NULL
HIV	NULL
gene	NULL
expression	NULL
both	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
PMA	NULL
.	NULL

Mutations	NULL
of	NULL
the	NULL
loop	NULL
(	NULL
+31/+34	NULL
)	NULL
or	NULL
the	NULL
stem	NULL
structure	NULL
(	NULL
+11/+14/+40/+43	NULL
)	NULL
were	NULL
very	NULL
defective	NULL
for	NULL
gene	NULL
expression	NULL
in	NULL
untreated	NULL
Jurkat	NULL
cells	NULL
but	NULL
each	NULL
was	NULL
induced	NULL
15	NULL
to	NULL
20-fold	NULL
in	NULL
PMA-treated	NULL
Jurkat	NULL
cells	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

The	NULL
ATAR-sense	NULL
construct	NULL
was	NULL
somewhat	NULL
defective	NULL
relative	NULL
to	NULL
wild-type	NULL
(	NULL
decreased	NULL
~2-fold	NULL
)	NULL
in	NULL
untreated	NULL
Jurkat	NULL
cells	NULL
but	NULL
its	NULL
gene	NULL
expression	NULL
was	NULL
induced	NULL
in	NULL
PMA-treated	NULL
Jurkat	NULL
cells	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

Coupling	NULL
the	NULL
enhancer	NULL
mutation	NULL
to	NULL
each	NULL
of	NULL
these	NULL
TAR	NULL
mutations	NULL
resulted	NULL
in	NULL
marked	NULL
changes	NULL
in	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
mutated	NULL
enhancer	NULL
coupled	NULL
to	NULL
either	NULL
the	NULL
loop	NULL
(	NULL
+31/	NULL
+34	NULL
)	NULL
or	NULL
the	NULL
stem	NULL
disruption	NULL
(	NULL
+11/+14/+40/	NULL
+43	NULL
)	NULL
constructs	NULL
resulted	NULL
in	NULL
no	NULL
detectable	NULL
gene	NULL
expression	NULL
in	NULL
either	NULL
untreated	NULL
or	NULL
PMA-treated	NULL
Jurkat	NULL
cells	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

Coupling	NULL
the	NULL
ATAR-sense	NULL
and	NULL
the	NULL
enhancer	NULL
mutations	NULL
resulted	NULL
in	NULL
decreased	NULL
gene	NULL
expression	NULL
in	NULL
untreated	NULL
Jurkat	NULL
cells	NULL
with	NULL
no	NULL
further	NULL
increase	NULL
in	NULL
PMA-treated	NULL
Jurkat	NULL
cells	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

The	NULL
severe	NULL
decreases	NULL
in	NULL
gene	NULL
expression	NULL
obtained	NULL
by	NULL
coupling	NULL
mutations	NULL
in	NULL
TAR	NULL
and	NULL
the	NULL
enhancer	NULL
suggest	NULL
a	NULL
synergy	NULL
between	NULL
these	NULL
two	NULL
elements	NULL
in	NULL
regulating	NULL
HIV	NULL
gene	NULL
expression	NULL
.	NULL

Furthermore	NULL
,	NULL
it	NULL
points	NULL
to	NULL
a	NULL
requirement	NULL
for	NULL
the	NULL
enhancer	NULL
element	NULL
in	NULL
regulating	NULL
PMA	NULL
induced	NULL
expression	NULL
of	NULL
HIV	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
we	NULL
can	NULL
not	NULL
rule	NULL
out	NULL
that	NULL
other	NULL
upstream	NULL
regulatory	NULL
elements	NULL
may	NULL
also	NULL
influence	NULL
PMA	NULL
induction	NULL
of	NULL
HIV	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

tat	NULL
is	NULL
required	NULL
for	NULL
TAR	NULL
independent	NULL
activation	NULL
of	NULL
HIV	NULL
in	NULL
PMA-treated	NULL
Jurkat	NULL
cells	NULL
It	NULL
was	NULL
important	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
tat	NULL
protein	NULL
(	NULL
Arya	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
;	NULL
Sodroski	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
;	NULL
Cullen	NULL
,	NULL
1986	NULL
;	NULL
Dayton	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Feinberg	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Fisher	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Rosen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
)	NULL
was	NULL
required	NULL
for	NULL
high	NULL
levels	NULL
of	NULL
gene	NULL
expression	NULL
with	NULL
HIV	NULL
TAR	NULL
mutants	NULL
in	NULL
PMA-treated	NULL
Jurkat	NULL
cells	NULL
.	NULL

A	NULL
deletion	NULL
of	NULL
the	NULL
cysteine	NULL
domains	NULL
in	NULL
the	NULL
tat	NULL
gene	NULL
was	NULL
4420	NULL
10000	NULL
8000	NULL
O	NULL
s24pgimi	NULL
6000	NULL
(	NULL
J	NULL
-	NULL
p24	NULL
pgiinl	NULL
(	NULL
PMA	NULL
50	NULL
ngimi	NULL
)	NULL
E	NULL
J	NULL
4000	NULL
~3	NULL
g	NULL
2000	NULL
o	NULL
.	NULL

__	NULL
PC	NULL
2T	NULL
Â°*~~	NULL
p	NULL
Â®	NULL
3	NULL
&	NULL
3	NULL
a	NULL
&	NULL
5	NULL
e	NULL
3	NULL
$	NULL
F	NULL
&	NULL
&	NULL
o	NULL
(	NULL
Â»	NULL
11/+14	NULL
}	NULL
(	NULL
240/+43	NULL
)	NULL
-	NULL
atat	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Expression	NULL
of	NULL
fat	NULL
mutants	NULL
in	NULL
unstimulated	NULL
and	NULL
PMA-stimulated	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
p24	NULL
Ag	NULL
(	NULL
pg/ml	NULL
!	NULL
)	NULL

detected	NULL
in	NULL
the	NULL
tissue	NULL
culture	NULL
media	NULL
from	NULL
either	NULL
untreated	NULL
or	NULL
PMA-stimulated	NULL
Jurkat	NULL
cells	NULL
at	NULL
48	NULL
h	NULL
post-transfection	NULL
for	NULL
the	NULL
wild-type	NULL
construct	NULL
or	NULL
the	NULL
wild-type	NULL
,	NULL
enhancer	NULL
,	NULL
4	NULL
bp	NULL
substitutions	NULL
of	NULL
the	NULL
loop	NULL
(	NULL
+31/+34	NULL
)	NULL
,	NULL
and	NULL
stem	NULL
secondary	NULL
structure	NULL
(	NULL
+11/+14	NULL
,	NULL
+40/+43	NULL
)	NULL
mutants	NULL
containing	NULL
an	NULL
additional	NULL
mutation	NULL
of	NULL
the	NULL
fat	NULL
gene	NULL
are	NULL
indicated	NULL
.	NULL

All	NULL
transfections	NULL
were	NULL
normalized	NULL
for	NULL
expression	NULL
of	NULL
the	NULL
RSV	NULL
CAT	NULL
.	NULL

The	NULL
clear	NULL
boxes	NULL
indicate	NULL
expression	NULL
in	NULL
untreated	NULL
Jurkat	NULL
cells	NULL
and	NULL
the	NULL
hatched	NULL
boxes	NULL
indicate	NULL
expression	NULL
in	NULL
PMA-treated	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
are	NULL
the	NULL
average	NULL
of	NULL
four	NULL
independent	NULL
experiments	NULL
with	NULL
the	NULL
standard	NULL
deviation	NULL
indicated	NULL
.	NULL

constructed	NULL
which	NULL
resulted	NULL
in	NULL
a	NULL
protein	NULL
defective	NULL
for	NULL
trans-activation	NULL
(	NULL
Garcia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Sadaie	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Ruben	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

Constructs	NULL
containing	NULL
this	NULL
tat	NULL
mutation	NULL
included	NULL
the	NULL
wild-type	NULL
construct	NULL
,	NULL
the	NULL
enhancer	NULL
mutant	NULL
,	NULL
the	NULL
loop	NULL
substitution	NULL
mutant	NULL
(	NULL
+31/+34	NULL
)	NULL
,	NULL
and	NULL
the	NULL
stem	NULL
disruption	NULL
mutant	NULL
(	NULL
+11/+14/+40+43	NULL
)	NULL
.	NULL

An	NULL
RSV	NULL
CAT	NULL
construct	NULL
confirmed	NULL
that	NULL
equal	NULL
transfection	NULL
efficiencies	NULL
were	NULL
maintained	NULL
in	NULL
these	NULL
experiments	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
4	NULL
,	NULL
the	NULL
wild-type	NULL
construct	NULL
gave	NULL
high	NULL
levels	NULL
of	NULL
expression	NULL
in	NULL
Jurkat	NULL
cells	NULL
in	NULL
both	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
PMA	NULL
.	NULL

However	NULL
,	NULL
constructs	NULL
containing	NULL
fat	NULL
deletions	NULL
were	NULL
extremely	NULL
defective	NULL
in	NULL
both	NULL
the	NULL
presence	NULL
and	NULL
the	NULL
absence	NULL
of	NULL
PMA	NULL
as	NULL
compared	NULL
with	NULL
the	NULL
wild-type	NULL
construct	NULL
.	NULL

This	NULL
indicated	NULL
that	NULL
tat	NULL
was	NULL
required	NULL
for	NULL
high	NULL
levels	NULL
of	NULL
gene	NULL
expression	NULL
with	NULL
both	NULL
the	NULL
wild-type	NULL
construct	NULL
and	NULL
with	NULL
TAR	NULL
mutants	NULL
in	NULL
activated	NULL
Jurkat	NULL
cells	NULL
.	NULL

Expression	NULL
of	NULL
HIV	NULL
constructs	NULL
in	NULL
unstimulated	NULL
and	NULL
PMA-stimulated	NULL
HeLa	NULL
cells	NULL
and	NULL
U937	NULL
cells	NULL
To	NULL
determine	NULL
whether	NULL
the	NULL
effects	NULL
of	NULL
TAR	NULL
region	NULL
mutants	NULL
seen	NULL
in	NULL
activated	NULL
Jurkat	NULL
cells	NULL
was	NULL
seen	NULL
on	NULL
other	NULL
cell	NULL
types	NULL
,	NULL
each	NULL
of	NULL
the	NULL
HIV	NULL
constructs	NULL
was	NULL
transfected	NULL
onto	NULL
either	NULL
untreated	NULL
or	NULL
PMA	NULL
-treated	NULL
HeLa	NULL
and	NULL
U937	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
5	NULL
,	NULL
the	NULL
level	NULL
of	NULL
expression	NULL
with	NULL
the	NULL
wild-type	NULL
HIV	NULL
construct	NULL
transfected	NULL
by	NULL
calcium	NULL
phosphate	NULL
precipitation	NULL
onto	NULL
HeLa	NULL
cells	NULL
was	NULL
markedly	NULL
decreased	NULL
as	NULL
compared	NULL
with	NULL
that	NULL
on	NULL
Jurkat	NULL
cells	NULL
.	NULL

Similar	NULL
levels	NULL
of	NULL
gene	NULL
expression	NULL
were	NULL
seen	NULL
when	NULL
these	NULL
constructs	NULL
were	NULL
introduced	NULL
by	NULL
electroporation	NULL
.	NULL

However	NULL
,	NULL
there	NULL
was	NULL
still	NULL
a	NULL
~2-fold	NULL
induction	NULL
in	NULL
p24	NULL
Ag	NULL
levels	NULL
of	NULL
the	NULL
wild-type	NULL
construct	NULL
by	NULL
PMA	NULL
.	NULL

Gene	NULL
expression	NULL
of	NULL
the	NULL
enhancer	NULL
mutant	NULL
and	NULL
the	NULL
ATAR-sense	NULL
construct	NULL
were	NULL
each	NULL
decreased	NULL
by	NULL
~2-fold	NULL
compared	NULL
with	NULL
the	NULL
wild-type	NULL
and	NULL
each	NULL
construct	NULL
was	NULL
induced	NULL
~2-fold	NULL
by	NULL
PMA	NULL
treatment	NULL
.	NULL

Mutations	NULL
of	NULL
the	NULL
SP1	NULL
,	NULL
TATA	NULL
or	NULL
TAR	NULL
region	NULL
mutations	NULL
(	NULL
+34	NULL
,	NULL
+31/+34	NULL
and	NULL
+11/+14/+40/+43	NULL
)	NULL
resulted	NULL
in	NULL
extremely	NULL
low	NULL
levels	NULL
of	NULL
p24	NULL
Ag	NULL
with	NULL
minimal	NULL
activation	NULL
by	NULL
PMA	NULL
(	NULL
Figure	NULL
5	NULL
)	NULL
.	NULL

These	NULL
constructs	NULL
were	NULL
also	NULL
introduced	NULL
into	NULL
U937	NULL
cells	NULL
by	NULL
electroporation	NULL
,	NULL
the	NULL
cells	NULL
divided	NULL
at	NULL
24	NULL
h	NULL
,	NULL
and	NULL
one	NULL
portion	NULL
of	NULL
the	NULL
cells	NULL
was	NULL
untreated	NULL
and	NULL
the	NULL
other	NULL
half	NULL
treated	NULL
with	NULL
1000	NULL
800	NULL
7	NULL
C	NULL
p24	NULL
pgim	NULL
!	NULL

IC	NULL
-	NULL
p24	NULL
pgimi	NULL
(	NULL
PMA	NULL
Songimi	NULL
)	NULL
E	NULL
&	NULL
.	NULL

3	NULL
4001	NULL
a.	NULL
o	NULL
LTI	NULL
_	NULL
T	NULL
a+	NULL
,	NULL
[	NULL
Lg	NULL
control	NULL
wud	NULL
TvpE	NULL
TATA	NULL
(	NULL
+24	NULL
)	NULL
Lauvese	NULL
)	NULL
ATAR-sanse	NULL
(	NULL
entre	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Expression	NULL
of	NULL
HIV	NULL
mutants	NULL
in	NULL
untreated	NULL
and	NULL
PMA-treated	NULL
HeLa	NULL
cells	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
p24	NULL
Ag	NULL
(	NULL
pg/m	NULL
!	NULL
)	NULL

detected	NULL
in	NULL
the	NULL
tissue	NULL
culture	NULL
media	NULL
at	NULL
96	NULL
h	NULL
post-transfection	NULL
for	NULL
the	NULL
wild-type	NULL
construct	NULL
and	NULL
mutations	NULL
of	NULL
the	NULL
enhancer	NULL
,	NULL
SP1	NULL
,	NULL
TATA	NULL
,	NULL
point	NULL
mutations	NULL
of	NULL
the	NULL
loop	NULL
(	NULL
+34	NULL
)	NULL
,	NULL
4	NULL
bp	NULL
substitutions	NULL
of	NULL
the	NULL
loop	NULL
(	NULL
+31/+34	NULL
)	NULL
,	NULL
primary	NULL
sequence	NULL
of	NULL
the	NULL
stem	NULL
(	NULL
ATAR-sense	NULL
)	NULL
and	NULL
disruption	NULL
of	NULL
the	NULL
stem	NULL
secondary	NULL
structure	NULL
(	NULL
+1i/+14	NULL
,	NULL
+40/+43	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

All	NULL
transfections	NULL
were	NULL
normalized	NULL
for	NULL
expression	NULL
of	NULL
RSV	NULL
CAT	NULL
.	NULL

The	NULL
clear	NULL
boxes	NULL
indicate	NULL
expression	NULL
in	NULL
untreated	NULL
HeLa	NULL
cells	NULL
and	NULL
the	NULL
hatched	NULL
boxes	NULL
indicate	NULL
expression	NULL
in	NULL
PMA-treated	NULL
HeLa	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
are	NULL
the	NULL
average	NULL
of	NULL
four	NULL
independent	NULL
experiments	NULL
with	NULL
the	NULL
standard	NULL
deviation	NULL
indicated	NULL
.	NULL

8000	NULL
C.	NULL
P2pgyim	NULL
6000	NULL
E2	NULL
]	NULL
-	NULL
P24	NULL
pgimt	NULL
(	NULL
PMA	NULL
â¬	NULL
8	NULL
4000	NULL
&	NULL
px	NULL
o	NULL
4	NULL
Co+Zn	NULL
8	NULL
Io	NULL
f	NULL
<	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Expression	NULL
of	NULL
HIV	NULL
mutants	NULL
in	NULL
untreated	NULL
and	NULL
PMA-treated	NULL
U937	NULL
cells	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
p24	NULL
Ag	NULL
(	NULL
pg/ml	NULL
!	NULL
)	NULL

detected	NULL
in	NULL
the	NULL
tissue	NULL
culture	NULL
media	NULL
at	NULL
48	NULL
h	NULL
post-transfection	NULL
for	NULL
the	NULL
wild-type	NULL
construct	NULL
and	NULL
mutations	NULL
of	NULL
the	NULL
enhancer	NULL
,	NULL
SP1	NULL
,	NULL
TATA	NULL
,	NULL
point	NULL
mutations	NULL
of	NULL
the	NULL
loop	NULL
(	NULL
+34	NULL
)	NULL
,	NULL
4	NULL
bp	NULL
substitutions	NULL
of	NULL
the	NULL
loop	NULL
+34	NULL
)	NULL
,	NULL
primary	NULL
sequence	NULL
of	NULL
the	NULL
stem	NULL
(	NULL
ATAR-sense	NULL
)	NULL
and	NULL
disruption	NULL
of	NULL
the	NULL
stem	NULL
secondary	NULL
structure	NULL
(	NULL
+11/+14	NULL
,	NULL
+40/+43	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

All	NULL
transfections	NULL
were	NULL
normalized	NULL
to	NULL
expression	NULL
of	NULL
RSV	NULL
CAT	NULL
.	NULL

The	NULL
clear	NULL
boxes	NULL
indicate	NULL
expression	NULL
in	NULL
untreated	NULL
U937	NULL
cells	NULL
and	NULL
the	NULL
hatched	NULL
boxes	NULL
indicate	NULL
expression	NULL
in	NULL
PMA-treated	NULL
U937	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
are	NULL
the	NULL
average	NULL
of	NULL
four	NULL
independent	NULL
experiments	NULL
with	NULL
the	NULL
standard	NULL
deviation	NULL
indicated	NULL
.	NULL

PMA	NULL
.	NULL

p24	NULL
Ag	NULL
levels	NULL
were	NULL
determined	NULL
at	NULL
48	NULL
h	NULL
post-transfection	NULL
(	NULL
Figure	NULL
6	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
results	NULL
seen	NULL
with	NULL
PMA	NULL
on	NULL
HeLa	NULL
and	NULL
Jurkat	NULL
cells	NULL
,	NULL
each	NULL
of	NULL
the	NULL
constructs	NULL
had	NULL
slightly	NULL
lower	NULL
levels	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMA	NULL
than	NULL
in	NULL
its	NULL
absence	NULL
.	NULL

This	NULL
decreased	NULL
gene	NULL
expression	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMA	NULL
was	NULL
not	NULL
due	NULL
to	NULL
cell	NULL
death	NULL
as	NULL
determined	NULL
by	NULL
equivalent	NULL
cell	NULL
viabilities	NULL
in	NULL
both	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
PMA	NULL
.	NULL

The	NULL
wild-type	NULL
construct	NULL
both	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
PMA	NULL
yielded	NULL
~6000	NULL
pg/ml	NULL
of	NULL
p24	NULL
.	NULL

The	NULL
enhancer	NULL
mutant	NULL
was	NULL
decreased	NULL
2-	NULL
to	NULL
3-fold	NULL
as	NULL
compared	NULL
with	NULL
the	NULL
wild-type	NULL
construct	NULL
both	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
PMA	NULL
.	NULL

Mutations	NULL
of	NULL
the	NULL
SP1	NULL
and	NULL
TATA	NULL
regions	NULL
were	NULL
decreased	NULL
>	NULL
50-fold	NULL
compared	NULL
with	NULL
the	NULL
wild-type	NULL
construct	NULL
(	NULL
Figure	NULL
6	NULL
)	NULL
.	NULL

HIV	NULL
activation	NULL
The	NULL
effects	NULL
of	NULL
various	NULL
TAR	NULL
region	NULL
mutations	NULL
was	NULL
much	NULL
less	NULL
pronounced	NULL
as	NULL
compared	NULL
with	NULL
the	NULL
wild-type	NULL
construct	NULL
in	NULL
untreated	NULL
U937	NULL
cells	NULL
than	NULL
Jurkat	NULL
cells	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
ATAR-sense	NULL
construct	NULL
was	NULL
decreased	NULL
~2-fold	NULL
(	NULL
Figure	NULL
6	NULL
)	NULL
.	NULL

Mutations	NULL
of	NULL
either	NULL
the	NULL
loop	NULL
(	NULL
+34	NULL
,	NULL
and	NULL
+31/+34	NULL
)	NULL
or	NULL
the	NULL
stem	NULL
structure	NULL
(	NULL
+11/+14/+40/	NULL
+43	NULL
)	NULL
were	NULL
decreased	NULL
~	NULL
3-fold	NULL
as	NULL
compared	NULL
with	NULL
the	NULL
wild-type	NULL
construct	NULL
in	NULL
both	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
PMA	NULL
(	NULL
Figure	NULL
6	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
all	NULL
the	NULL
TAR	NULL
mutants	NULL
exhibited	NULL
slightly	NULL
decreased	NULL
expression	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMA	NULL
as	NULL
compared	NULL
with	NULL
its	NULL
absence	NULL
.	NULL

Discussion	NULL
A	NULL
number	NULL
of	NULL
regulatory	NULL
regions	NULL
in	NULL
the	NULL
HIV	NULL
LTR	NULL
are	NULL
critical	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
HIV	NULL
gene	NULL
expression	NULL
.	NULL

Previous	NULL
mutagenesis	NULL
and	NULL
transient	NULL
expression	NULL
assays	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
enhancer	NULL
(	NULL
Kaufman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Muesing	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Nabel	NULL
and	NULL
Baltimore	NULL
,	NULL
1987	NULL
;	NULL
Tong-Starksen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Gaynor	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
SP1	NULL
(	NULL
Jones	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Harrich	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
,	NULL
TATA	NULL
(	NULL
Garcia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
,	NULL
1989	NULL
;	NULL
Muesing	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Jones	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
and	NULL
TAR	NULL
(	NULL
Rosen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
;	NULL
Peterlin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Garcia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Feng	NULL
and	NULL
Holland	NULL
,	NULL
1988	NULL
;	NULL
Hauber	NULL
and	NULL
Cullen	NULL
,	NULL
1988	NULL
;	NULL
Jakobovits	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Berkhout	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Braddock	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Garcia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Laspia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Selby	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
regions	NULL
were	NULL
critical	NULL
for	NULL
high	NULL
level	NULL
basal	NULL
and	NULL
tar-induced	NULL
activity	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
mutations	NULL
within	NULL
these	NULL
regions	NULL
were	NULL
placed	NULL
into	NULL
infectious	NULL
proviral	NULL
constructs	NULL
.	NULL

These	NULL
constructs	NULL
were	NULL
assayed	NULL
before	NULL
the	NULL
onset	NULL
of	NULL
significant	NULL
viral	NULL
replication	NULL
in	NULL
Jurkat	NULL
,	NULL
U937	NULL
and	NULL
HeLa	NULL
cells	NULL
in	NULL
both	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
PMA	NULL
.	NULL

Previous	NULL
data	NULL
has	NULL
indicated	NULL
that	NULL
several	NULL
upstream	NULL
regulatory	NULL
domains	NULL
in	NULL
the	NULL
HIV	NULL
LTR	NULL
are	NULL
required	NULL
for	NULL
high	NULL
level	NULL
gene	NULL
expression	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
Kaufman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Nabel	NULL
and	NULL
Baltimore	NULL
,	NULL
1987	NULL
;	NULL
Siekevitz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Tong-Starksen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Durand	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Shaw	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Crabtree	NULL
,	NULL
1989	NULL
)	NULL
.	NULL

These	NULL
studies	NULL
demonstrated	NULL
that	NULL
the	NULL
enhancer	NULL
region	NULL
containing	NULL
two	NULL
NF-xB	NULL
motifs	NULL
was	NULL
one	NULL
element	NULL
required	NULL
for	NULL
efficient	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
Nabel	NULL
and	NULL
Baltimore	NULL
,	NULL
1987	NULL
;	NULL
Kaufman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Tong-Starksen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
Jurkat	NULL
or	NULL
other	NULL
cells	NULL
by	NULL
PMA	NULL
and	NULL
PHA	NULL
resulted	NULL
in	NULL
increased	NULL
binding	NULL
to	NULL
the	NULL
NF-xB	NULL
motifs	NULL
(	NULL
Nabel	NULL
and	NULL
Baltimore	NULL
,	NULL
1987	NULL
;	NULL
Wu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988a	NULL
)	NULL
.	NULL

This	NULL
increased	NULL
binding	NULL
was	NULL
correlated	NULL
with	NULL
increased	NULL
expression	NULL
from	NULL
the	NULL
HIV	NULL
LTR	NULL
and	NULL
this	NULL
expression	NULL
was	NULL
augmented	NULL
by	NULL
tat	NULL
(	NULL
Kaufman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Nabel	NULL
and	NULL
Baltimore	NULL
,	NULL
1987	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
demonstrated	NULL
that	NULL
isolated	NULL
mutations	NULL
of	NULL
the	NULL
enhancer	NULL
were	NULL
not	NULL
required	NULL
for	NULL
high	NULL
level	NULL
gene	NULL
activation	NULL
in	NULL
any	NULL
of	NULL
the	NULL
cell	NULL
lines	NULL
tested	NULL
.	NULL

Neither	NULL
did	NULL
mutations	NULL
of	NULL
the	NULL
enhancer	NULL
region	NULL
alone	NULL
markedly	NULL
alter	NULL
HIV	NULL
gene	NULL
expression	NULL
in	NULL
Jurkat	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
PMA	NULL
.	NULL

Similar	NULL
lack	NULL
of	NULL
dependence	NULL
on	NULL
the	NULL
enhancer	NULL
element	NULL
using	NULL
assays	NULL
of	NULL
viral	NULL
growth	NULL
have	NULL
recently	NULL
been	NULL
obtained	NULL
with	NULL
infectious	NULL
viral	NULL
constructs	NULL
(	NULL
Leonard	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
studies	NULL
with	NULL
HIV	NULL
LTR	NULL
CAT	NULL
constructs	NULL
which	NULL
are	NULL
strongly	NULL
induced	NULL
in	NULL
PMA-treated	NULL
Jurkat	NULL
cells	NULL
(	NULL
Nabel	NULL
and	NULL
Baltimore	NULL
,	NULL
1987	NULL
;	NULL
Siekevitz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Tong-Starksen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Kaufman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
,	NULL
our	NULL
results	NULL
suggest	NULL
that	NULL
either	NULL
viral	NULL
regulatory	NULL
proteins	NULL
and/or	NULL
cis	NULL
acting	NULL
control	NULL
elements	NULL
in	NULL
the	NULL
wild-type	NULL
proviral	NULL
construct	NULL
may	NULL
inhibit	NULL
high	NULL
levels	NULL
of	NULL
PMA	NULL
induction	NULL
.	NULL

Mutations	NULL
of	NULL
the	NULL
SP1	NULL
and	NULL
TATA	NULL
motifs	NULL
were	NULL
previously	NULL
found	NULL
to	NULL
result	NULL
in	NULL
severe	NULL
defects	NULL
in	NULL
basal	NULL
and	NULL
rat-induced	NULL
gene	NULL
expression	NULL
by	NULL
transient	NULL
gene-expression	NULL
assays	NULL
(	NULL
Jones	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Garcia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Muesing	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Jones	NULL
et	NULL
4421	NULL
D.Harrich	NULL
et	NULL
al	NULL
.	NULL

al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Garcia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Harrich	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

These	NULL
results	NULL
were	NULL
confirmed	NULL
when	NULL
these	NULL
mutations	NULL
were	NULL
introduced	NULL
into	NULL
proviral	NULL
constructs	NULL
.	NULL

Both	NULL
of	NULL
these	NULL
mutations	NULL
resulted	NULL
in	NULL
severe	NULL
defects	NULL
in	NULL
viral	NULL
gene	NULL
expression	NULL
on	NULL
all	NULL
cell	NULL
lines	NULL
tested	NULL
.	NULL

These	NULL
mutants	NULL
appeared	NULL
to	NULL
have	NULL
a	NULL
very	NULL
low	NULL
induction	NULL
by	NULL
PMA	NULL
.	NULL

The	NULL
TAR	NULL
region	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
required	NULL
for	NULL
activation	NULL
by	NULL
tat	NULL
.	NULL

This	NULL
region	NULL
is	NULL
the	NULL
site	NULL
for	NULL
DNA	NULL
binding	NULL
by	NULL
cellular	NULL
proteins	NULL
UBP1	NULL
and	NULL
UBP2	NULL
(	NULL
Wu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988a	NULL
;	NULL
Garcia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
this	NULL
region	NULL
is	NULL
the	NULL
site	NULL
for	NULL
a	NULL
stable	NULL
stem-loop	NULL
structure	NULL
at	NULL
the	NULL
RNA	NULL
level	NULL
(	NULL
Muesing	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Feng	NULL
and	NULL
Holland	NULL
,	NULL
1988	NULL
;	NULL
Garcia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Selby	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

The	NULL
maintenance	NULL
of	NULL
both	NULL
the	NULL
stem	NULL
structure	NULL
and	NULL
the	NULL
primary	NULL
sequence	NULL
of	NULL
the	NULL
loop	NULL
were	NULL
required	NULL
for	NULL
tat	NULL
activation	NULL
(	NULL
Feng	NULL
and	NULL
Holland	NULL
,	NULL
1988	NULL
;	NULL
Hauber	NULL
and	NULL
Cullen	NULL
,	NULL
1988	NULL
;	NULL
Jakobovits	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Garcia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Selby	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

Mutations	NULL
in	NULL
the	NULL
TAR	NULL
region	NULL
were	NULL
tested	NULL
which	NULL
eliminated	NULL
stem	NULL
base	NULL
pairing	NULL
(	NULL
+11/+14/+40/	NULL
+43	NULL
)	NULL
,	NULL
that	NULL
introduced	NULL
either	NULL
a	NULL
single	NULL
base	NULL
pair	NULL
mutation	NULL
(	NULL
+34	NULL
)	NULL
or	NULL
a	NULL
4	NULL
bp	NULL
substitution	NULL
(	NULL
+31/+34	NULL
)	NULL
in	NULL
the	NULL
loop	NULL
,	NULL
or	NULL
that	NULL
extensively	NULL
changed	NULL
the	NULL
primary	NULL
sequence	NULL
of	NULL
TAR	NULL
while	NULL
preserving	NULL
stem	NULL
base	NULL
pairing	NULL
and	NULL
stem	NULL
energy	NULL
(	NULL
ATAR-sense	NULL
)	NULL
.	NULL

These	NULL
TAR	NULL
mutations	NULL
exhibited	NULL
very	NULL
different	NULL
effects	NULL
on	NULL
different	NULL
cell	NULL
lines	NULL
.	NULL

On	NULL
untreated	NULL
Jurkat	NULL
cells	NULL
,	NULL
the	NULL
mutations	NULL
of	NULL
the	NULL
primary	NULL
sequence	NULL
of	NULL
TAR	NULL
resulted	NULL
in	NULL
only	NULL
2-fold	NULL
decreases	NULL
in	NULL
gene	NULL
expression	NULL
compared	NULL
with	NULL
the	NULL
wild-type	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
loop	NULL
sequences	NULL
or	NULL
disruption	NULL
of	NULL
the	NULL
stem	NULL
secondary	NULL
structure	NULL
resulted	NULL
in	NULL
10	NULL
to	NULL
35-fold	NULL
decreases	NULL
in	NULL
gene	NULL
expression	NULL
compared	NULL
with	NULL
wild-type	NULL
.	NULL

However	NULL
,	NULL
expression	NULL
of	NULL
these	NULL
TAR	NULL
mutants	NULL
was	NULL
much	NULL
less	NULL
defective	NULL
in	NULL
PMA-treated	NULL
Jurkat	NULL
cells	NULL
being	NULL
reduced	NULL
only	NULL
2	NULL
to	NULL
3-fold	NULL
compared	NULL
with	NULL
the	NULL
wild-type	NULL
.	NULL

This	NULL
marked	NULL
induction	NULL
of	NULL
gene	NULL
expression	NULL
with	NULL
these	NULL
TAR	NULL
mutants	NULL
was	NULL
not	NULL
seen	NULL
in	NULL
either	NULL
PMA-treated	NULL
U937	NULL
or	NULL
HeLa	NULL
cells	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
alternative	NULL
mechanisms	NULL
of	NULL
activation	NULL
may	NULL
occur	NULL
in	NULL
PMA	NULL
stimulated	NULL
Jurkat	NULL
cells	NULL
to	NULL
circumvent	NULL
TAR	NULL
region	NULL
mutations	NULL
.	NULL

By	NULL
coupling	NULL
TAR	NULL
mutants	NULL
to	NULL
mutants	NULL
in	NULL
the	NULL
enhancer	NULL
region	NULL
,	NULL
increased	NULL
expression	NULL
from	NULL
these	NULL
proviral	NULL
constructs	NULL
was	NULL
eliminated	NULL
in	NULL
PMA-treated	NULL
Jurkat	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
enhancer	NULL
is	NULL
an	NULL
essential	NULL
regulatory	NULL
element	NULL
required	NULL
for	NULL
PMA	NULL
inducton	NULL
of	NULL
HIV	NULL
gene	NULL
expression	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TAR	NULL
mutations	NULL
.	NULL

Synergistic	NULL
effects	NULL
of	NULL
the	NULL
enhancer	NULL
and	NULL
TAR	NULL
mutations	NULL
in	NULL
regulating	NULL
HIV	NULL
gene	NULL
expression	NULL
were	NULL
seen	NULL
in	NULL
both	NULL
untreated	NULL
and	NULL
PMA-treated	NULL
Jurkat	NULL
cells	NULL
,	NULL
suggesting	NULL
potential	NULL
interactions	NULL
of	NULL
cellular	NULL
factors	NULL
binding	NULL
to	NULL
these	NULL
sites	NULL
(	NULL
Garcia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
cellular	NULL
factors	NULL
,	NULL
tat	NULL
was	NULL
also	NULL
required	NULL
for	NULL
high	NULL
level	NULL
gene	NULL
expression	NULL
in	NULL
PMA-treated	NULL
Jurkat	NULL
cells	NULL
.	NULL

Due	NULL
to	NULL
the	NULL
deleterious	NULL
effects	NULL
of	NULL
mutations	NULL
of	NULL
the	NULL
SP1	NULL
and	NULL
TATA	NULL
elements	NULL
on	NULL
HIV	NULL
gene	NULL
expression	NULL
,	NULL
it	NULL
was	NULL
not	NULL
possible	NULL
to	NULL
determine	NULL
whether	NULL
these	NULL
elements	NULL
were	NULL
also	NULL
involved	NULL
in	NULL
increasing	NULL
HIV	NULL
gene	NULL
expression	NULL
in	NULL
PMA-treated	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
NFAT	NULL
binding	NULL
sites	NULL
(	NULL
Durand	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Shaw	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Crabtree	NULL
,	NULL
1989	NULL
)	NULL
in	NULL
the	NULL
HIV	NULL
LTR	NULL
did	NULL
not	NULL
appear	NULL
to	NULL
play	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
regulating	NULL
HIV	NULL
gene	NULL
expression	NULL
in	NULL
PMA-stimulated	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
high	NULL
level	NULL
of	NULL
gene	NULL
expression	NULL
in	NULL
PMA-treated	NULL
lymphocytes	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TAR	NULL
mutations	NULL
may	NULL
be	NULL
due	NULL
to	NULL
suboptimal	NULL
activation	NULL
by	NULL
tat	NULL
due	NULL
to	NULL
decreased	NULL
affinity	NULL
to	NULL
tat	NULL
binding	NULL
to	NULL
mutated	NULL
TAR	NULL
RNAs	NULL
(	NULL
Dingwall	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
a	NULL
model	NULL
in	NULL
which	NULL
tat	NULL
may	NULL
interact	NULL
with	NULL
both	NULL
upstream	NULL
and	NULL
downstream	NULL
cellular	NULL
factors	NULL
to	NULL
increase	NULL
HIV	NULL
gene	NULL
expression	NULL
.	NULL

Similar	NULL
to	NULL
results	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
TAR	NULL
region	NULL
mutations	NULL
4422	NULL
of	NULL
the	NULL
loop	NULL
or	NULL
stem	NULL
structure	NULL
resulted	NULL
in	NULL
large	NULL
defects	NULL
in	NULL
gene	NULL
expression	NULL
on	NULL
HeLa	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
expression	NULL
with	NULL
these	NULL
mutants	NULL
by	NULL
PMA	NULL
was	NULL
minimal	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
TAR	NULL
region	NULL
mutants	NULL
introduced	NULL
into	NULL
U937	NULL
cells	NULL
was	NULL
much	NULL
less	NULL
pronounced	NULL
than	NULL
seen	NULL
on	NULL
HeLa	NULL
or	NULL
untreated	NULL
Jurkat	NULL
cells	NULL
.	NULL

Mutations	NULL
of	NULL
the	NULL
loop	NULL
and	NULL
stem	NULL
disruption	NULL
were	NULL
only	NULL
3	NULL
to	NULL
4-fold	NULL
reduced	NULL
compared	NULL
with	NULL
the	NULL
wild-type	NULL
construct	NULL
on	NULL
U937	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
all	NULL
constructs	NULL
were	NULL
reduced	NULL
in	NULL
expression	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMA	NULL
.	NULL

This	NULL
was	NULL
not	NULL
due	NULL
to	NULL
cell	NULL
death	NULL
as	NULL
determined	NULL
by	NULL
studies	NULL
of	NULL
cell	NULL
viability	NULL
,	NULL
but	NULL
it	NULL
may	NULL
reflect	NULL
the	NULL
effect	NULL
of	NULL
PMA	NULL
on	NULL
monocyte	NULL
differentiation	NULL
(	NULL
Rovera	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1979	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
modulation	NULL
in	NULL
either	NULL
the	NULL
level	NULL
or	NULL
activity	NULL
of	NULL
cellular	NULL
regulatory	NULL
proteins	NULL
in	NULL
different	NULL
cells	NULL
may	NULL
alter	NULL
the	NULL
phenotype	NULL
of	NULL
constructs	NULL
containing	NULL
TAR	NULL
mutations	NULL
.	NULL

The	NULL
studies	NULL
outlined	NULL
herein	NULL
define	NULL
the	NULL
activity	NULL
of	NULL
HIV	NULL
LTR	NULL
mutants	NULL
in	NULL
proviral	NULL
constructs	NULL
.	NULL

Due	NULL
to	NULL
the	NULL
fact	NULL
that	NULL
PMA	NULL
was	NULL
toxic	NULL
to	NULL
cells	NULL
with	NULL
prolonged	NULL
incubation	NULL
,	NULL
assays	NULL
were	NULL
performed	NULL
before	NULL
the	NULL
onset	NULL
of	NULL
significant	NULL
viral	NULL
replication	NULL
.	NULL

This	NULL
was	NULL
reflected	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
reverse	NULL
transcriptase	NULL
at	NULL
the	NULL
time	NULL
of	NULL
the	NULL
assays	NULL
.	NULL

However	NULL
,	NULL
with	NULL
prolonged	NULL
infec-tion	NULL
,	NULL
significant	NULL
levels	NULL
of	NULL
reverse	NULL
transcriptase	NULL
were	NULL
detected	NULL
with	NULL
a	NULL
number	NULL
of	NULL
these	NULL
constructs	NULL
.	NULL

Further	NULL
studies	NULL
using	NULL
high	NULL
titered	NULL
virus	NULL
stocks	NULL
will	NULL
be	NULL
required	NULL
to	NULL
determine	NULL
the	NULL
kinetics	NULL
of	NULL
viral	NULL
growth	NULL
for	NULL
these	NULL
various	NULL
mutant	NULL
viruses	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
viruses	NULL
containing	NULL
TAR	NULL
region	NULL
mutations	NULL
coupled	NULL
to	NULL
different	NULL
upstream	NULL
regulatory	NULL
regions	NULL
will	NULL
be	NULL
required	NULL
to	NULL
determine	NULL
other	NULL
potential	NULL
regions	NULL
required	NULL
for	NULL
efficient	NULL
viral	NULL
growth	NULL
in	NULL
activated	NULL
Jurkat	NULL
cells	NULL
.	NULL

These	NULL
studies	NULL
will	NULL
be	NULL
important	NULL
in	NULL
defining	NULL
potential	NULL
sites	NULL
for	NULL
tat	NULL
action	NULL
in	NULL
activated	NULL
T	NULL
lymphocytes	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
Plasmid	NULL
constructs	NULL
Two	NULL
HIV-1	NULL
LTR	NULL
shuttle	NULL
vectors	NULL
were	NULL
constructed	NULL
.	NULL

For	NULL
the	NULL
5	NULL
LTR	NULL
shuttle	NULL
,	NULL
a	NULL
BamHI	NULL
restriction	NULL
site	NULL
was	NULL
inserted	NULL
just	NULL
upstream	NULL
of	NULL
-454	NULL
from	NULL
the	NULL
start	NULL
of	NULL
transcription	NULL
by	NULL
site-directed	NULL
mutagenesis	NULL
of	NULL
ARV	NULL
2B	NULL
(	NULL
Luciw	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1984	NULL
)	NULL
.	NULL

A	NULL
BamHI-Narl	NULL
(	NULL
+186	NULL
)	NULL
fragment	NULL
of	NULL
this	NULL
HIV-1	NULL
LTR	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
corresponding	NULL
unique	NULL
sites	NULL
of	NULL
pUC18	NULL
(	NULL
Be/II*/Smal~	NULL
polylinker	NULL
by	NULL
linker	NULL
addition	NULL
)	NULL
.	NULL

For	NULL
the	NULL
3	NULL
'	NULL
LTR	NULL
shuttle	NULL
,	NULL
an	NULL
Asp718	NULL
(	NULL
+8581	NULL
)	NULL
-Narl	NULL
(	NULL
+186	NULL
)	NULL
frag-ment	NULL
,	NULL
which	NULL
includes	NULL
the	NULL
LTR	NULL
from	NULL
ARV	NULL
2B	NULL
,	NULL
was	NULL
cloned	NULL
into	NULL
pUC18	NULL
(	NULL
BgllI*/Smal~	NULL
)	NULL
.	NULL

Aval	NULL
(	NULL
-160	NULL
)	NULL
~-HindllI	NULL
(	NULL
+83	NULL
)	NULL
fragments	NULL
from	NULL
previously	NULL
made	NULL
LTR	NULL
mutants	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
two	NULL
shuttle	NULL
vectors	NULL
.	NULL

The	NULL
BamHI-Narl	NULL
(	NULL
+186	NULL
)	NULL
fragments	NULL
from	NULL
these	NULL
5Â°	NULL
LTR	NULL
shuttles	NULL
were	NULL
subcloned	NULL
into	NULL
an	NULL
ARV	NULL
2B	NULL
BamHI-EcoRI	NULL
(	NULL
+5299	NULL
)	NULL
pUC19	NULL
(	NULL
SphIC	NULL
)	NULL
construct	NULL
(	NULL
designated	NULL
as	NULL
the	NULL
5	NULL
``	NULL
LTR	NULL
arm	NULL
)	NULL
and	NULL
the	NULL
Asp718	NULL
(	NULL
+8581	NULL
)	NULL
(	NULL
+186	NULL
)	NULL
pUC	NULL
18	NULL
construct	NULL
(	NULL
designated	NULL
as	NULL
the	NULL
3'LTR	NULL
arm	NULL
)	NULL
.	NULL

To	NULL
assemble	NULL
the	NULL
proviral	NULL
construct	NULL
,	NULL
a	NULL
Bg/I-EcoRI	NULL
(	NULL
+5299	NULL
)	NULL
fragment	NULL
from	NULL
each	NULL
of	NULL
the	NULL
LTR	NULL
arms	NULL
was	NULL
gel	NULL
isolated	NULL
,	NULL
ligated	NULL
and	NULL
positive	NULL
clones	NULL
were	NULL
confirmed	NULL
by	NULL
dideoxy	NULL
sequencing	NULL
.	NULL

Finally	NULL
,	NULL
a	NULL
SpAI	NULL
(	NULL
+999	NULL
)	NULL
-Nceol	NULL
(	NULL
+5111	NULL
)	NULL
fragment	NULL
from	NULL
PBH	NULL
10	NULL
was	NULL
cloned	NULL
into	NULL
each	NULL
of	NULL
the	NULL
proviral	NULL
constructs	NULL
(	NULL
Shaw	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1984	NULL
)	NULL
.	NULL

The	NULL
Atat	NULL
proviral	NULL
constructs	NULL
contain	NULL
an	NULL
internal	NULL
deletion	NULL
from	NULL
+5409	NULL
to	NULL
+5492	NULL
which	NULL
deletes	NULL
the	NULL
putative	NULL
zinc	NULL
finger	NULL
.	NULL

The	NULL
expression	NULL
plasmid	NULL
RSV	NULL
CAT	NULL
is	NULL
described	NULL
elsewhere	NULL
(	NULL
Gorman	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1982	NULL
)	NULL
.	NULL

Transfections	NULL
HeLa	NULL
plates	NULL
were	NULL
maintained	NULL
on	NULL
complete	NULL
Iscove	NULL
's	NULL
medium	NULL
containing	NULL
penicillin	NULL
and	NULL
streptomycin	NULL
.	NULL

Plates	NULL
were	NULL
split	NULL
the	NULL
day	NULL
prior	NULL
to	NULL
transfection	NULL
so	NULL
that	NULL
each	NULL
100	NULL
mm	NULL
plate	NULL
was	NULL
50-70	NULL
%	NULL
confluent	NULL
at	NULL
the	NULL
time	NULL
of	NULL
transfec-tion	NULL
.	NULL

Using	NULL
the	NULL
calcium	NULL
phosphate	NULL
precipitation	NULL
technique	NULL
,	NULL
10	NULL
ug	NULL
of	NULL
each	NULL
proviral	NULL
DNA	NULL
and	NULL
5	NULL
ug	NULL
RSV	NULL
CAT	NULL
DNA	NULL
were	NULL
co-transfected	NULL
onto	NULL
identically	NULL
prepared	NULL
plates	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
glycerol	NULL
shocked	NULL
at	NULL
4	NULL
h	NULL
post-transfection	NULL
.	NULL

The	NULL
media	NULL
from	NULL
one	NULL
set	NULL
of	NULL
duplicate	NULL
plates	NULL
was	NULL
removed	NULL
and	NULL
replaced	NULL
with	NULL
complete	NULL
Iscove	NULL
's	NULL
containing	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
at	NULL
50	NULL
ng/ml	NULL
(	NULL
PMA	NULL
,	NULL
Sigma	NULL
)	NULL
at	NULL
24	NULL
h	NULL
post-transfection	NULL
.	NULL

Jurkat	NULL
cells	NULL
and	NULL
U937	NULL
cells	NULL
were	NULL
maintained	NULL
on	NULL
Iscove	NULL
's	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
plus	NULL
penicillin	NULL
and	NULL
streptomycin	NULL
.	NULL

Cells	NULL
were	NULL
grown	NULL
to	NULL
a	NULL
density	NULL
of	NULL
1	NULL
x	NULL
10Â°	NULL
cells/ml	NULL
and	NULL
supplemented	NULL
with	NULL
fresh	NULL
media	NULL
16-20	NULL
h	NULL
prior	NULL
to	NULL
electroporation	NULL
.	NULL

Cells	NULL
(	NULL
2	NULL
x	NULL
10	NULL
``	NULL
)	NULL
were	NULL
electroporated	NULL
using	NULL
the	NULL
BRL	NULL
cell	NULL
porator	NULL
at	NULL
250	NULL
V	NULL
,	NULL
1180	NULL
pF	NULL
and	NULL
low	NULL
resistance	NULL
,	NULL
in	NULL
growth	NULL
media	NULL
containing	NULL
the	NULL
proviral	NULL
DNA	NULL
(	NULL
10	NULL
pg/ml	NULL
!	NULL
)	NULL

plus	NULL
RSV	NULL
CAT	NULL
(	NULL
5	NULL
ug/ml	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
split	NULL
into	NULL
identical	NULL
flasks	NULL
at	NULL
24	NULL
h	NULL
post-transfection	NULL
and	NULL
one	NULL
set	NULL
was	NULL
supplemented	NULL
with	NULL
PMA	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
.	NULL

p24	NULL
ELISA	NULL
Culture	NULL
supernatants	NULL
were	NULL
collected	NULL
48	NULL
h	NULL
post-transfection	NULL
(	NULL
for	NULL
U937	NULL
and	NULL
Jurkat	NULL
cells	NULL
)	NULL
and	NULL
at	NULL
96	NULL
h	NULL
for	NULL
HeLa	NULL
cells	NULL
.	NULL

HIV-1	NULL
p24	NULL
antigen	NULL
in	NULL
culture	NULL
supernatants	NULL
was	NULL
detected	NULL
using	NULL
the	NULL
Abbott	NULL
Laboratories	NULL
'	NULL
HIVAG-1	NULL
enzyme	NULL
immunoassay	NULL
.	NULL

To	NULL
normalize	NULL
for	NULL
transfection	NULL
efficiencies	NULL
,	NULL
the	NULL
cells	NULL
for	NULL
each	NULL
transfection	NULL
were	NULL
harvested	NULL
and	NULL
assayed	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
product	NULL
.	NULL

Reverse	NULL
transcriptase	NULL
assay	NULL
Culture	NULL
supernatants	NULL
were	NULL
assayed	NULL
for	NULL
reverse	NULL
transcriptase	NULL
activity	NULL
as	NULL
described	NULL
(	NULL
Melish	NULL
er	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
cleared	NULL
cell	NULL
supernatants	NULL
were	NULL
precipitated	NULL
with	NULL
PEG	NULL
(	NULL
30	NULL
%	NULL
PEG	NULL
6000	NULL
,	NULL
0.4	NULL
M	NULL
NaC1	NULL
)	NULL
,	NULL
spun	NULL
at	NULL
2000	NULL
g	NULL
for	NULL
30	NULL
min	NULL
,	NULL
and	NULL
the	NULL
resulting	NULL
pellet	NULL
was	NULL
resuspended	NULL
in	NULL
TNE	NULL
(	NULL
10	NULL
mM	NULL
Tris	NULL
pH	NULL
8.0	NULL
,	NULL
1.0	NULL
mM	NULL
EDTA	NULL
,	NULL
100	NULL
mM	NULL
NaCl	NULL
)	NULL
.	NULL

Samples	NULL
were	NULL
frozen	NULL
and	NULL
thawed	NULL
twice	NULL
and	NULL
added	NULL
to	NULL
a	NULL
reaction	NULL
containing	NULL
appropriate	NULL
buffers	NULL
plus	NULL
The	NULL
templates	NULL
used	NULL
were	NULL
poly	NULL
(	NULL
rA	NULL
)	NULL
/oligo	NULL
(	NULL
dT	NULL
)	NULL
,	NULL
and	NULL
separately	NULL
poly	NULL
(	NULL
dA	NULL
)	NULL
/oligo	NULL
(	NULL
dT	NULL
)	NULL
(	NULL
Pharmacia	NULL
)	NULL
.	NULL

Acknowledgements	NULL
We	NULL
thank	NULL
Charles	NULL
Leavitt	NULL
for	NULL
preparation	NULL
of	NULL
this	NULL
manuscript	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Public	NULL
Health	NULL
Service	NULL
Grants	NULL
(	NULL
AI25288	NULL
and	NULL
29167	NULL
)	NULL
and	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Veterans	NULL
'	NULL
Administration	NULL
.	NULL

R.G	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
a	NULL
Faculty	NULL
Research	NULL
Award	NULL
from	NULL
the	NULL
American	NULL
Cancer	NULL
Society	NULL
and	NULL
J.G	NULL
.	NULL

from	NULL
the	NULL
UCLA	NULL
Medical	NULL
Scientist	NULL
Training	NULL
Program	NULL
.	NULL

References	NULL
Arya	NULL
,	NULL
S.K	NULL
.	NULL

,	NULL
Gou	NULL
,	NULL
C.	NULL
,	NULL
Josephs	NULL
,	NULL
S.F	NULL
.	NULL

and	NULL
Wong-Staal	NULL
,	NULL
F	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Science	NULL
,	NULL
229	NULL
,	NULL
69-73	NULL
.	NULL

Arya.S.K	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Nature	NULL
,	NULL
328	NULL
,	NULL
548-550	NULL
.	NULL

Barre-Sinousi	NULL
,	NULL
F	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
Science	NULL
,	NULL
220	NULL
,	NULL
868-871	NULL
.	NULL

Berkhout.B	NULL
.	NULL

,	NULL
Silverman	NULL
.	NULL

and	NULL
Jeang	NULL
,	NULL
K.T..	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
,	NULL
59	NULL
,	NULL
273-282	NULL
.	NULL

Braddock	NULL
.	NULL

M.	NULL
,	NULL
Chambers	NULL
,	NULL
A.	NULL
,	NULL
Wilson	NULL
,	NULL
W.	NULL
,	NULL
Esnouf	NULL
,	NULL
M.P	NULL
.	NULL

,	NULL
Adams	NULL
,	NULL
S.E	NULL
.	NULL

,	NULL
Kingsman	NULL
,	NULL
.A.J	NULL
.	NULL

and	NULL
Kingsman	NULL
,	NULL
S.M	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Cell	NULL
,	NULL
58	NULL
,	NULL
269-279	NULL
.	NULL

Crabtree	NULL
,	NULL
G.R..	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
,	NULL
243	NULL
,	NULL
355-361	NULL
.	NULL

Cullen	NULL
,	NULL
B.R	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Cell	NULL
,	NULL
46	NULL
,	NULL
973-982	NULL
.	NULL

Dayton	NULL
,	NULL
A.1	NULL
.	NULL

,	NULL
Sodroski	NULL
,	NULL
J.G	NULL
.	NULL

,	NULL
Rosen	NULL
,	NULL
C	NULL
.	NULL

A..	NULL
Goh	NULL
.	NULL

W.C.	NULL
and	NULL
Haseltine	NULL
,	NULL
W.	NULL
A	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Cell	NULL
,	NULL
44	NULL
,	NULL
941-947	NULL
.	NULL

Dingwall	NULL
,	NULL
.C	NULL
.	NULL

,	NULL
Emberg.L	NULL
.	NULL

,	NULL
Gait	NULL
,	NULL
M.J..	NULL
,	NULL
Green	NULL
,	NULL
S.M	NULL
.	NULL

,	NULL
Heaphy	NULL
,	NULL
S.	NULL
,	NULL
Kenn	NULL
,	NULL
J.	NULL
,	NULL
Lowe	NULL
,	NULL
A.D.	NULL
,	NULL
Sirugh	NULL
,	NULL
M.	NULL
,	NULL
Skinner	NULL
.	NULL

,	NULL
M.A	NULL
.	NULL

and	NULL
Volerio.R	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
86	NULL
,	NULL
6925-6929	NULL
.	NULL

Durand	NULL
,	NULL
D.B	NULL
.	NULL

,	NULL
Shaw	NULL
,	NULL
J.P.	NULL
,	NULL
Bush	NULL
,	NULL
M.R	NULL
.	NULL

,	NULL
Replogle	NULL
,	NULL
R.E..	NULL
Belagage.R	NULL
.	NULL

and	NULL
Crabtree	NULL
,	NULL
G.R	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
8	NULL
.	NULL

1715-1724	NULL
.	NULL

Feinberg	NULL
,	NULL
M.B	NULL
.	NULL

,	NULL
Jarrett	NULL
,	NULL
R.F	NULL
.	NULL

,	NULL
Aldovini	NULL
,	NULL
A.	NULL
,	NULL
Gallo	NULL
,	NULL
R.C	NULL
.	NULL

and	NULL
Wong-Staal	NULL
,	NULL
F	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Cell	NULL
,	NULL
46	NULL
,	NULL
807-817	NULL
.	NULL

Feng	NULL
.	NULL

$	NULL
.	NULL

and	NULL
Holland	NULL
,	NULL
E.C	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Nature	NULL
,	NULL
334	NULL
.	NULL

165-167	NULL
.	NULL

Fisher	NULL
,	NULL
A.G	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Nature	NULL
,	NULL
320	NULL
,	NULL
367-371	NULL
.	NULL

Gallo	NULL
,	NULL
R.C	NULL
.	NULL

er	NULL
al	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Science	NULL
,	NULL
224	NULL
,	NULL
500-503	NULL
.	NULL

Garcia	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Wu	NULL
,	NULL
F.K	NULL
.	NULL

,	NULL
Mitsuyasu	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Gaynor	NULL
.	NULL

R.B	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
7	NULL
.	NULL

3143-3147	NULL
.	NULL

Garcia	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Harrich	NULL
,	NULL
D.	NULL
,	NULL
Pearson.L	NULL
.	NULL

,	NULL
Mitsuyasu	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Gaynor	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
EMBO	NULL
J	NULL
,	NULL
7	NULL
,	NULL
3143-3147	NULL
.	NULL

Garcia	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
Harrich	NULL
,	NULL
.D	NULL
.	NULL

,	NULL
Soultanakis	NULL
,	NULL
E.	NULL
,	NULL
Wu	NULL
,	NULL
F.	NULL
,	NULL
Mitsuyasu.R	NULL
.	NULL

and	NULL
Gaynor.R.B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
,	NULL
8	NULL
,	NULL
765-778	NULL
.	NULL

Gatignol	NULL
,	NULL
A.	NULL
,	NULL
Kumar	NULL
,	NULL
A.	NULL
,	NULL
Rabson	NULL
,	NULL
A.	NULL
and	NULL
Jeang.K.T	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
86	NULL
,	NULL
7828-7832	NULL
.	NULL

Gaynor.R.B	NULL
.	NULL

,	NULL
Kuwabara	NULL
,	NULL
M.D	NULL
.	NULL

,	NULL
Wu	NULL
,	NULL
FK..	NULL
Garcia	NULL
J.A..	NULL
Harrich	NULL
,	NULL
.D	NULL
.	NULL

,	NULL
Briskin	NULL
,	NULL
M.	NULL
,	NULL
Well	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Sigman	NULL
,	NULL
D.	NULL
$	NULL
S	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
83	NULL
,	NULL
9406-9410	NULL
.	NULL

Gaynor.R	NULL
.	NULL

,	NULL
Soultanakis	NULL
,	NULL
E.	NULL
,	NULL
Kawabara.M	NULL
.	NULL

,	NULL
Garcia	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Sigman.D.S	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
86	NULL
,	NULL
4858-4862	NULL
.	NULL

Gorman	NULL
,	NULL
C	NULL
.	NULL

M.	NULL
,	NULL
Moffat	NULL
,	NULL
L.F	NULL
.	NULL

and	NULL
Howard.B.H	NULL
.	NULL

(	NULL
1982	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
2	NULL
,	NULL
1044-1051	NULL
.	NULL

Harada	NULL
,	NULL
$	NULL
.	NULL

,	NULL
Koyamagi	NULL
,	NULL
Y..	NULL
Nakashima	NULL
,	NULL
N.	NULL
,	NULL
Kobayashi.N	NULL
.	NULL

and	NULL
Yamamoto.N	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Virology	NULL
,	NULL
154	NULL
,	NULL
249-256	NULL
.	NULL

Harrich	NULL
,	NULL
D..	NULL
Garcia	NULL
,	NULL
J.	NULL
,	NULL
Wu	NULL
,	NULL
F.	NULL
,	NULL
Mitsuyasu	NULL
,	NULL
R..	NULL
Gonzalez.J	NULL
.	NULL

and	NULL
Gaynor	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
63	NULL
,	NULL
2585-2591	NULL
.	NULL

Hauber.J	NULL
.	NULL

and	NULL
Cullen	NULL
,	NULL
B.R	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
62	NULL
,	NULL
673-679	NULL
.	NULL

Jakobovits	NULL
,	NULL
A.	NULL
,	NULL
Smith	NULL
,	NULL
D.H..	NULL
Jakobovitz	NULL
,	NULL
E.B	NULL
.	NULL

and	NULL
Capon.D.J	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
8	NULL
,	NULL
255-261	NULL
.	NULL

HIV	NULL
activation	NULL
Jones	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Kadonga.J.T	NULL
.	NULL

,	NULL
Luciw	NULL
,	NULL
P	NULL
.	NULL

A.	NULL
and	NULL
Tjian	NULL
,	NULL
R	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Science	NULL
,	NULL
232	NULL
,	NULL
755-759	NULL
.	NULL

Jones	NULL
,	NULL
K.A..	NULL
Luciw	NULL
,	NULL
P.A	NULL
.	NULL

and	NULL
Duchange.N	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Genes	NULL
.	NULL

Dev	NULL
.	NULL

,	NULL
2	NULL
,	NULL
1101-1114	NULL
.	NULL

Kaufman	NULL
,	NULL
J.D	NULL
.	NULL

,	NULL
Valandra	NULL
,	NULL
G.	NULL
,	NULL
Roderiguez	NULL
,	NULL
G.	NULL
,	NULL
Bushar	NULL
,	NULL
G.	NULL
,	NULL
Giri	NULL
,	NULL
C	NULL
.	NULL

and	NULL
Norcross	NULL
,	NULL
M.A	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
7	NULL
,	NULL
3759-3766	NULL
.	NULL

Kawakami	NULL
,	NULL
K.	NULL
,	NULL
Scheidereit	NULL
,	NULL
C	NULL
.	NULL

and	NULL
Roeder	NULL
,	NULL
R.G	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
85	NULL
,	NULL
4700-4704	NULL
.	NULL

Laspia	NULL
,	NULL
M.F	NULL
.	NULL

,	NULL
Rice	NULL
,	NULL
A.	NULL
and	NULL
Mathews	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Cell	NULL
,	NULL
59	NULL
,	NULL
283-292	NULL
.	NULL

Leonard	NULL
,	NULL
J.	NULL
,	NULL
Parrot	NULL
,	NULL
C.	NULL
,	NULL
White	NULL
,	NULL
A.B	NULL
.	NULL

,	NULL
Turner	NULL
,	NULL
W.	NULL
,	NULL
Ross	NULL
,	NULL
E.K	NULL
.	NULL

,	NULL
Martin	NULL
,	NULL
N.	NULL
A.	NULL
and	NULL
Rabson	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
63	NULL
,	NULL
4919-4924	NULL
.	NULL

Levy	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Hoffman	NULL
,	NULL
A.D.	NULL
,	NULL
Kramer	NULL
,	NULL
$	NULL
.M	NULL
.	NULL

,	NULL
Landis	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Shimabukuro	NULL
,	NULL
J.M	NULL
.	NULL

and	NULL
Oshimo	NULL
,	NULL
L.S	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Science	NULL
,	NULL
225	NULL
,	NULL
840-842	NULL
.	NULL

Lu	NULL
,	NULL
Y.	NULL
,	NULL
Stenzel	NULL
,	NULL
M.	NULL
,	NULL
Sodroski	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Haseltine	NULL
,	NULL
W.	NULL
A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
63	NULL
,	NULL
4115-4119	NULL
.	NULL

Luciw	NULL
,	NULL
P.A	NULL
.	NULL

,	NULL
Potler	NULL
,	NULL
S.J	NULL
.	NULL

,	NULL
Steimer	NULL
,	NULL
K.	NULL
,	NULL
Dina	NULL
,	NULL
D	NULL
.	NULL

and	NULL
Levy	NULL
.J	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Nature	NULL
,	NULL
312	NULL
,	NULL
760-763	NULL
.	NULL

Melish	NULL
,	NULL
M.E	NULL
.	NULL

,	NULL
Marchette	NULL
,	NULL
N.J.	NULL
,	NULL
Kaplan	NULL
,	NULL
J.C.	NULL
,	NULL
Kihira	NULL
,	NULL
S.	NULL
,	NULL
Ching	NULL
,	NULL
D	NULL
.	NULL

and	NULL
Ho	NULL
,	NULL
D.D	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Nature	NULL
,	NULL
337	NULL
,	NULL
288-290	NULL
.	NULL

Muesing	NULL
,	NULL
M.A	NULL
.	NULL

,	NULL
Smith	NULL
,	NULL
D.H.	NULL
and	NULL
Capon	NULL
,	NULL
D.J	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Cell	NULL
,	NULL
48	NULL
,	NULL
691-701	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
and	NULL
Baltimore	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Nature	NULL
,	NULL
326	NULL
,	NULL
711-713	NULL
.	NULL

Nakajima	NULL
,	NULL
N.	NULL
,	NULL
Horikishi	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Roeder	NULL
,	NULL
R.G	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
8	NULL
,	NULL
4028-4040	NULL
.	NULL

Peterlin	NULL
,	NULL
B	NULL
.	NULL

M.	NULL
,	NULL
Luciw	NULL
,	NULL
P.A	NULL
.	NULL

,	NULL
Bart	NULL
,	NULL
P.J	NULL
.	NULL

and	NULL
Walker	NULL
,	NULL
M.D	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
83	NULL
,	NULL
9734-9738	NULL
.	NULL

Rosen	NULL
,	NULL
C	NULL
.	NULL

A.	NULL
,	NULL
Sodroski	NULL
,	NULL
J.G	NULL
.	NULL

and	NULL
Haseltine	NULL
,	NULL
W.	NULL
A	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Cell	NULL
,	NULL
41	NULL
,	NULL
813-823	NULL
.	NULL

Rosen	NULL
,	NULL
C.A	NULL
.	NULL

,	NULL
Sodroski.J.G	NULL
.	NULL

,	NULL
Goh	NULL
,	NULL
W.C.	NULL
,	NULL
Dayton	NULL
,	NULL
A.I	NULL
.	NULL

,	NULL
Loppke	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Haseltine	NULL
,	NULL
W.A	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Nature	NULL
,	NULL
319	NULL
,	NULL
555-559	NULL
.	NULL

Rovera	NULL
,	NULL
G.	NULL
,	NULL
Santoli	NULL
,	NULL
D	NULL
.	NULL

and	NULL
Damsky	NULL
,	NULL
C	NULL
.	NULL

(	NULL
1979	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
76	NULL
.	NULL

2779-2783	NULL
.	NULL

Ruben	NULL
,	NULL
$	NULL
.	NULL

,	NULL
Perkins	NULL
,	NULL
A.	NULL
,	NULL
Purcell	NULL
,	NULL
R	NULL
.	NULL

Joung	NULL
,	NULL
K.	NULL
,	NULL
Sia.R	NULL
.	NULL

,	NULL
Burghoff	NULL
,	NULL
R.	NULL
,	NULL
Haseltine	NULL
,	NULL
W.A	NULL
.	NULL

and	NULL
Rosen	NULL
,	NULL
C.A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
63	NULL
,	NULL
1-8	NULL
.	NULL

Sadaie	NULL
,	NULL
M.R	NULL
.	NULL

,	NULL
Rappaport.J	NULL
.	NULL

,	NULL
Benter.T	NULL
.	NULL

,	NULL
Josephs	NULL
,	NULL
S.F	NULL
.	NULL

,	NULL
Willis	NULL
,	NULL
R.	NULL
and	NULL
Wong-Staal	NULL
,	NULL
F	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
85	NULL
,	NULL
9224-9228	NULL
.	NULL

Selby	NULL
,	NULL
M.J.	NULL
,	NULL
Bain	NULL
,	NULL
E.S	NULL
.	NULL

,	NULL
Luciw	NULL
,	NULL
P	NULL
.	NULL

A.	NULL
and	NULL
Peterlin	NULL
,	NULL
B.M	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

,	NULL
3	NULL
,	NULL
547-558	NULL
.	NULL

Shaw.G.M	NULL
.	NULL

,	NULL
Hahn	NULL
,	NULL
B.H	NULL
.	NULL

,	NULL
Arya	NULL
,	NULL
S.K	NULL
.	NULL

,	NULL
Groopman	NULL
,	NULL
J.E	NULL
.	NULL

,	NULL
Gallo	NULL
,	NULL
R.C	NULL
.	NULL

and	NULL
Wong-Staal	NULL
,	NULL
F	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Science	NULL
,	NULL
226	NULL
,	NULL
1165-1171	NULL
.	NULL

Shaw	NULL
,	NULL
J.P.	NULL
,	NULL
Utz	NULL
,	NULL
P.	NULL
,	NULL
Durand.T	NULL
.	NULL

,	NULL
Toole	NULL
,	NULL
J.	NULL
,	NULL
Emmel	NULL
,	NULL
E	NULL
.	NULL

and	NULL
Crabtree	NULL
,	NULL
G	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Science	NULL
,	NULL
241	NULL
,	NULL
202-206	NULL
.	NULL

Siekevitz	NULL
,	NULL
M.	NULL
,	NULL
Josephs	NULL
,	NULL
S.F	NULL
.	NULL

,	NULL
Dukovich	NULL
,	NULL
M.	NULL
,	NULL
Peffer	NULL
,	NULL
N.	NULL
,	NULL
Wong-Staal	NULL
,	NULL
F	NULL
.	NULL

and	NULL
Greene	NULL
,	NULL
W.C.	NULL
(	NULL
1987	NULL
)	NULL
Science	NULL
,	NULL
238	NULL
,	NULL
1575-1578	NULL
.	NULL

Sodroski	NULL
,	NULL
J.	NULL
,	NULL
Rosen	NULL
,	NULL
C.	NULL
,	NULL
Wong-Staal	NULL
,	NULL
F.	NULL
,	NULL
Salahuddin	NULL
,	NULL
$	NULL
.Z	NULL
.	NULL

,	NULL
Popovic	NULL
,	NULL
M.	NULL
,	NULL
Arya	NULL
,	NULL
S.	NULL
,	NULL
Gallo	NULL
,	NULL
R.C	NULL
.	NULL

and	NULL
Haseltine	NULL
,	NULL
W.	NULL
A	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Science	NULL
,	NULL
227	NULL
,	NULL
171-173	NULL
.	NULL

Tong-Starksen	NULL
,	NULL
$	NULL
.E	NULL
.	NULL

,	NULL
Luciw	NULL
,	NULL
P	NULL
.	NULL

A.	NULL
and	NULL
Peterlin	NULL
,	NULL
B.M	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
84	NULL
,	NULL
6845-6849	NULL
.	NULL

Wu	NULL
,	NULL
F.	NULL
,	NULL
Garcia	NULL
,	NULL
J.	NULL
,	NULL
Mitsuyasu	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Gaynor	NULL
,	NULL
(	NULL
1988a	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
62	NULL
,	NULL
218-225	NULL
.	NULL

Wu	NULL
,	NULL
F.K	NULL
.	NULL

,	NULL
Garcia	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Harrich	NULL
,	NULL
D	NULL
.	NULL

and	NULL
Gaynor	NULL
,	NULL
R.B	NULL
.	NULL

(	NULL
1988b	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
7	NULL
.	NULL

2117-2129	NULL
.	NULL

Received	NULL
on	NULL
April	NULL
17	NULL
,	NULL
1990	NULL
;	NULL
revised	NULL
on	NULL
August	NULL
21	NULL
,	NULL
1990	NULL
4423	NULL

